WO1994004693A2 - Novel plants and processes for obtaining them - Google Patents
Novel plants and processes for obtaining them Download PDFInfo
- Publication number
- WO1994004693A2 WO1994004693A2 PCT/GB1993/001821 GB9301821W WO9404693A2 WO 1994004693 A2 WO1994004693 A2 WO 1994004693A2 GB 9301821 W GB9301821 W GB 9301821W WO 9404693 A2 WO9404693 A2 WO 9404693A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- sgp
- protein
- starch
- donor
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 45
- 230000008569 process Effects 0.000 title description 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 213
- 229920002472 Starch Polymers 0.000 claims abstract description 105
- 235000019698 starch Nutrition 0.000 claims abstract description 105
- 239000008107 starch Substances 0.000 claims abstract description 103
- 108090000790 Enzymes Proteins 0.000 claims abstract description 84
- 102000004190 Enzymes Human genes 0.000 claims abstract description 83
- 101000582729 Zea mays Probable UDP-arabinopyranose mutase 1 Proteins 0.000 claims abstract description 71
- 108010062764 glycogenin Proteins 0.000 claims abstract description 39
- 102000011054 glycogenin Human genes 0.000 claims abstract description 39
- 240000008042 Zea mays Species 0.000 claims description 69
- 241000196324 Embryophyta Species 0.000 claims description 60
- 239000002299 complementary DNA Substances 0.000 claims description 28
- 108020004414 DNA Proteins 0.000 claims description 20
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 4
- 241000209149 Zea Species 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 3
- 241000209504 Poaceae Species 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 235000007244 Zea mays Nutrition 0.000 claims description 2
- 241000227653 Lycopersicon Species 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 43
- 238000003786 synthesis reaction Methods 0.000 abstract description 23
- 102000004169 proteins and genes Human genes 0.000 description 177
- 235000018102 proteins Nutrition 0.000 description 173
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 101
- 229940088598 enzyme Drugs 0.000 description 81
- 108090000765 processed proteins & peptides Proteins 0.000 description 62
- 230000000694 effects Effects 0.000 description 53
- 150000001413 amino acids Chemical class 0.000 description 49
- 239000008103 glucose Substances 0.000 description 45
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 44
- 235000001014 amino acid Nutrition 0.000 description 43
- 229940024606 amino acid Drugs 0.000 description 43
- 241000482268 Zea mays subsp. mays Species 0.000 description 39
- 239000000872 buffer Substances 0.000 description 34
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 32
- 235000005822 corn Nutrition 0.000 description 32
- 239000000523 sample Substances 0.000 description 32
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 31
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 30
- 235000009973 maize Nutrition 0.000 description 30
- 238000000746 purification Methods 0.000 description 26
- 238000011534 incubation Methods 0.000 description 23
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 description 21
- 102000004196 processed proteins & peptides Human genes 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- 229920002527 Glycogen Polymers 0.000 description 20
- 238000006243 chemical reaction Methods 0.000 description 20
- 229940096919 glycogen Drugs 0.000 description 20
- 239000000284 extract Substances 0.000 description 19
- 239000000203 mixture Substances 0.000 description 19
- 150000001720 carbohydrates Chemical class 0.000 description 18
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 17
- 235000014633 carbohydrates Nutrition 0.000 description 17
- 230000029087 digestion Effects 0.000 description 17
- 238000005194 fractionation Methods 0.000 description 17
- 210000003205 muscle Anatomy 0.000 description 17
- 239000000499 gel Substances 0.000 description 15
- 150000002500 ions Chemical class 0.000 description 15
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 15
- WFPZSXYXPSUOPY-ROYWQJLOSA-N ADP alpha-D-glucoside Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=CN=C(C=2N=C1)N)OP(O)(=O)OP(O)(=O)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WFPZSXYXPSUOPY-ROYWQJLOSA-N 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 108090000344 1,4-alpha-Glucan Branching Enzyme Proteins 0.000 description 12
- 102000003925 1,4-alpha-Glucan Branching Enzyme Human genes 0.000 description 12
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 12
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000007068 beta-elimination reaction Methods 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 239000000370 acceptor Substances 0.000 description 11
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 11
- 150000004676 glycans Chemical class 0.000 description 11
- 230000007062 hydrolysis Effects 0.000 description 11
- 238000006460 hydrolysis reaction Methods 0.000 description 11
- 239000008188 pellet Substances 0.000 description 11
- 229920001282 polysaccharide Polymers 0.000 description 11
- 239000005017 polysaccharide Substances 0.000 description 11
- 230000037452 priming Effects 0.000 description 11
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 10
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 10
- 241000283973 Oryctolagus cuniculus Species 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 238000005119 centrifugation Methods 0.000 description 10
- 230000001419 dependent effect Effects 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 230000009467 reduction Effects 0.000 description 10
- 238000006722 reduction reaction Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 229920001503 Glucan Polymers 0.000 description 9
- 229920002684 Sepharose Polymers 0.000 description 9
- 108010039811 Starch synthase Proteins 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 241000894007 species Species 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 102000003886 Glycoproteins Human genes 0.000 description 8
- 108090000288 Glycoproteins Proteins 0.000 description 8
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 239000007921 spray Substances 0.000 description 8
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 7
- 244000061456 Solanum tuberosum Species 0.000 description 7
- 235000002595 Solanum tuberosum Nutrition 0.000 description 7
- 235000013339 cereals Nutrition 0.000 description 7
- 230000002430 glycogenolytic effect Effects 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- 229910000033 sodium borohydride Inorganic materials 0.000 description 7
- 239000012279 sodium borohydride Substances 0.000 description 7
- 239000012588 trypsin Substances 0.000 description 7
- 239000004475 Arginine Substances 0.000 description 6
- 101710096830 DNA-3-methyladenine glycosylase Proteins 0.000 description 6
- 102100039128 DNA-3-methyladenine glycosylase Human genes 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 239000000020 Nitrocellulose Substances 0.000 description 6
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 6
- 102000004142 Trypsin Human genes 0.000 description 6
- 108090000631 Trypsin Proteins 0.000 description 6
- 238000005903 acid hydrolysis reaction Methods 0.000 description 6
- 108090000637 alpha-Amylases Proteins 0.000 description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 6
- 229910052786 argon Inorganic materials 0.000 description 6
- 108010019077 beta-Amylase Proteins 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 229920001220 nitrocellulos Polymers 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 210000002706 plastid Anatomy 0.000 description 6
- 230000010152 pollination Effects 0.000 description 6
- 239000001632 sodium acetate Substances 0.000 description 6
- 235000017281 sodium acetate Nutrition 0.000 description 6
- 229920002498 Beta-glucan Polymers 0.000 description 5
- 108010001483 Glycogen Synthase Proteins 0.000 description 5
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 5
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 5
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 5
- 239000004473 Threonine Substances 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 235000021307 Triticum Nutrition 0.000 description 5
- 102000048175 UTP-glucose-1-phosphate uridylyltransferases Human genes 0.000 description 5
- 102000004139 alpha-Amylases Human genes 0.000 description 5
- 229940024171 alpha-amylase Drugs 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 230000008436 biogenesis Effects 0.000 description 5
- 230000008021 deposition Effects 0.000 description 5
- 239000003112 inhibitor Substances 0.000 description 5
- 239000011565 manganese chloride Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 4
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 4
- 102000003793 Fructokinases Human genes 0.000 description 4
- 108090000156 Fructokinases Proteins 0.000 description 4
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 4
- 102100022624 Glucoamylase Human genes 0.000 description 4
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 102000001105 Phosphofructokinases Human genes 0.000 description 4
- 108010069341 Phosphofructokinases Proteins 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 4
- 102000006995 beta-Glucosidase Human genes 0.000 description 4
- 108010047754 beta-Glucosidase Proteins 0.000 description 4
- 230000008238 biochemical pathway Effects 0.000 description 4
- GNGACRATGGDKBX-UHFFFAOYSA-N dihydroxyacetone phosphate Chemical compound OCC(=O)COP(O)(O)=O GNGACRATGGDKBX-UHFFFAOYSA-N 0.000 description 4
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229960002591 hydroxyproline Drugs 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 239000012521 purified sample Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 4
- 230000009261 transgenic effect Effects 0.000 description 4
- 239000003656 tris buffered saline Substances 0.000 description 4
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 3
- 239000005695 Ammonium acetate Substances 0.000 description 3
- 229920000945 Amylopectin Polymers 0.000 description 3
- 229920000856 Amylose Polymers 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 229920002271 DEAE-Sepharose Polymers 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 108700023224 Glucose-1-phosphate adenylyltransferases Proteins 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 102000009569 Phosphoglucomutase Human genes 0.000 description 3
- 102000009097 Phosphorylases Human genes 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 101710167959 Putative UTP-glucose-1-phosphate uridylyltransferase Proteins 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 108010028144 alpha-Glucosidases Proteins 0.000 description 3
- 229940043376 ammonium acetate Drugs 0.000 description 3
- 235000019257 ammonium acetate Nutrition 0.000 description 3
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical class [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000000287 crude extract Substances 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 3
- 238000001641 gel filtration chromatography Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 108091000115 phosphomannomutase Proteins 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 238000004007 reversed phase HPLC Methods 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 238000004885 tandem mass spectrometry Methods 0.000 description 3
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 2
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- PQMRRAQXKWFYQN-UHFFFAOYSA-N 1-phenyl-2-sulfanylideneimidazolidin-4-one Chemical compound S=C1NC(=O)CN1C1=CC=CC=C1 PQMRRAQXKWFYQN-UHFFFAOYSA-N 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 2
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 2
- 108010021582 Glucokinase Proteins 0.000 description 2
- 102000004195 Isomerases Human genes 0.000 description 2
- 108090000769 Isomerases Proteins 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108010073135 Phosphorylases Proteins 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 241000196248 Prototheca zopfii Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 108010043934 Sucrose synthase Proteins 0.000 description 2
- 108700006291 Sucrose-phosphate synthases Proteins 0.000 description 2
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 2
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 108700023183 UTP-glucose-1-phosphate uridylyltransferases Proteins 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 244000083398 Zea diploperennis Species 0.000 description 2
- 235000007241 Zea diploperennis Nutrition 0.000 description 2
- 238000003916 acid precipitation Methods 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 2
- 125000000266 alpha-aminoacyl group Chemical group 0.000 description 2
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 2
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 2
- 239000001099 ammonium carbonate Substances 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000013213 extrapolation Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 2
- 238000002169 hydrotherapy Methods 0.000 description 2
- 210000004201 immune sera Anatomy 0.000 description 2
- 229940042743 immune sera Drugs 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 238000001038 ionspray mass spectrometry Methods 0.000 description 2
- FOMCONPAMXXLBX-MQHGYYCBSA-N isopanose Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H](O)[C@H]([C@H](O)[C@@H](O)C=O)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FOMCONPAMXXLBX-MQHGYYCBSA-N 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 230000037039 plant physiology Effects 0.000 description 2
- 108010032725 pyrophosphate-fructose 6-phosphate 1-phosphotransferase Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 108010009751 sucrose-phosphatase Proteins 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000003260 vortexing Methods 0.000 description 2
- ONQVTASTMOLDNH-YJQGPUDQSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxy-1-(4-nitrophenyl)hexan-1-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)C1=CC=C([N+]([O-])=O)C=C1 ONQVTASTMOLDNH-YJQGPUDQSA-N 0.000 description 1
- PAWSVPVNIXFKOS-IHWYPQMZSA-N (Z)-2-aminobutenoic acid Chemical compound C\C=C(/N)C(O)=O PAWSVPVNIXFKOS-IHWYPQMZSA-N 0.000 description 1
- IKRZCYCTPYDXML-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;hydrochloride Chemical compound Cl.OC(=O)CC(O)(C(O)=O)CC(O)=O IKRZCYCTPYDXML-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- IFBHRQDFSNCLOZ-ZIQFBCGOSA-N 4-nitrophenyl alpha-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-ZIQFBCGOSA-N 0.000 description 1
- IFBHRQDFSNCLOZ-RMPHRYRLSA-N 4-nitrophenyl beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-RMPHRYRLSA-N 0.000 description 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 1
- 108010000700 Acetolactate synthase Proteins 0.000 description 1
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 235000003276 Apios tuberosa Nutrition 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000010744 Arachis villosulicarpa Nutrition 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 244000188595 Brassica sinapistrum Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004970 Chain extender Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- UQBOJOOOTLPNST-UHFFFAOYSA-N Dehydroalanine Chemical compound NC(=C)C(O)=O UQBOJOOOTLPNST-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 1
- 240000006497 Dianthus caryophyllus Species 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 235000002723 Dioscorea alata Nutrition 0.000 description 1
- 235000007056 Dioscorea composita Nutrition 0.000 description 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 1
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 1
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 1
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 1
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 235000001950 Elaeis guineensis Nutrition 0.000 description 1
- 244000127993 Elaeis melanococca Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000009617 Inorganic Pyrophosphatase Human genes 0.000 description 1
- 108010009595 Inorganic Pyrophosphatase Proteins 0.000 description 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 1
- 108010025915 Nitrite Reductases Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 244000133018 Panax trifolius Species 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 108091034057 RNA (poly(A)) Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 240000003829 Sorghum propinquum Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 108010043943 Starch Phosphorylase Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 1
- 241000209138 Tripsacum Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000746970 Zea luxurians Species 0.000 description 1
- 235000017556 Zea mays subsp parviglumis Nutrition 0.000 description 1
- 241000209127 Zea perennis Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- FEUZQZOWFKSOAL-ZSOUGHPYSA-N acetic acid (2S,3R,4R,5R)-2,3,4,6-tetramethoxyhexane-1,5-diol Chemical compound C(C)(=O)O.CO[C@@H](CO)[C@@H](OC)[C@H](OC)[C@H](O)COC FEUZQZOWFKSOAL-ZSOUGHPYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- HXXFSFRBOHSIMQ-VFUOTHLCSA-N alpha-D-glucose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@@H]1O HXXFSFRBOHSIMQ-VFUOTHLCSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000002358 autolytic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 108010031100 chloroplast transit peptides Proteins 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229950010772 glucose-1-phosphate Drugs 0.000 description 1
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 235000020121 low-fat milk Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- RUJILUJOOCOSRO-WJMYNTJYSA-N maltooctaose Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](O[C@H](O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](O[C@@H]7[C@H](O[C@H](O)[C@H](O)[C@H]7O)CO)[C@H](O)[C@H]6O)CO)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O RUJILUJOOCOSRO-WJMYNTJYSA-N 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 229910001437 manganese ion Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 229950000964 pepstatin Drugs 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- -1 phenylthiohydantoin amino acid Chemical class 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 210000001916 photosynthetic cell Anatomy 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 238000005932 reductive alkylation reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000015801 regulation of glycogen metabolic process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000003345 scintillation counting Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 108040005733 triose-phosphate:phosphate antiporter activity proteins Proteins 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
Definitions
- This invention relates to novel plants having an altered ability to synthesise starch, and to processes for obtaining such novel plants.
- Starch is an important end-product of carbon fixation during photosynthesis in leaves and is an important storage product in seeds and fruits.
- Starch comprises up to 75% of the grain dry weight in cereals. In economic terms, the starch produced by the edible portions of three grain crops, wheat, rice and maize, provide approximately two-thirds of the world's food calculated as calories.
- Starch is synthesised in the plastid compartment (the chloroplast in photosynthetic cells or the amyloplast in non-photosyntiietic cells).
- the biochemical pathway of starch biosynthesis in leaves has been well-characterised and is shown in Figure 1.
- the abbreviations used are: G-3-P, glyceraldehyde-3-phosphate; DHAP, dihydroxyacetone phosphate; P., orthophosphate; PP., inorganic pyrophosphate; ADPG/ADPglucose, adenosine diphosphate glucose; ATP, adenosine triphosphate; UDPG/UDPglucose, uridine diphosphate glucose.
- the reactions are catalysed by the following enzymes: 1) phosphoglycerate kinase/glyceraldehyde-3-phosphate dehydrogenase, 2) triose-phosphate isomerase, 3) aldolase, 4) fructose-l,6-bisphosphatase, 5) hexose phosphate isomerase, 6) phosphoglucomutase, 7) ADP-glucose pyrophosphorylase, 8) starch synthase, 9) UDP-glucose pyrophosphorylase, 10) sucrose phosphate synthase, 11) sucrose phosphatase, 12) orthophosphate/ triose phosphate translocator, 13) inorganic pyrophosphatase.
- enzymes 1) phosphoglycerate kinase/glyceraldehyde-3-phosphate dehydrogenase, 2) triose-phosphate isomerase, 3) aldolase, 4)
- Figure 2 shows the metabolic pathway of starch biosynthesis in maize endosperm. The abbreviations used are the same as in Figure 1. The reactions are catalysed by the following enzymes: 1) sucrose synthase, 2)
- UDP-glucose pyrophosphorylase 3) hexokinase, 4) phosphoglucomutase, 5) hexose-phosphate isomerase,
- PP.-dependent phosphofructokinase 8 aldolase, 9) triose-phosphate isomerase, 10) hexose-phosphate translocator, 11) ADP-glucose pyrophosphorylase,
- glycogen is deposited rather than starch. It is now well established that glycogen synthesis is initiated on a protein primer which remains covalently attached to the mature macromolecule. Recent work on glycogen deposition has identified a new enzyme: glycogenin or self glucosylating protein (SGP) which acts as a primer.
- SGP self glucosylating protein
- the protein primer serves as the anchor on which the oligosaccharide is constructed and on which glycogen is built (Kennedy et al, 1985, Membranes and Muscle ed. by MC Berman et al, IRL Press Oxford/ICSU Press, pp65-84).
- the linkage between the oligosaccharide and glycogenin involves a novel carbohydrate-protein bond, via the hydroxyl group of tyrosine (Rodriguez and Whelan, 1985, Biochem Biophys Res Commun, 132:829-836).
- the discovery of glycogenin as a covalent component of the glycogen molecule was followed by the discovery in muscle and other tissues of a glycogen-free form that could be revealed by glucosylation from
- the self-glucosylating protein (SGP) in muscle i ⁇ not present as such, but is part of a larger molecule (proglycogen) (Lomako et al, 1990,
- glycogenin protein from rabbit skeletal muscle has been seguenced by Campbell and
- glycoprotein primer may be a universal feature for the synthesis of polysaccharides.
- proteins have been identified as potential priming molecules for carbohydrate synthesis. None of these proteins, however, has been associated with a polysaccharide macromolecule.
- covalently bound protein primer
- a method of producing a plant with altered starch synthesising ability comprising stably incorporating into the genome of a recipient plant at least one donor gene encoding a starch primer.
- This invention is based on our discovery that the enzyme reactions catalyzed by glycogenin are also important in the starch biosynthetic pathway of plant organs.
- SGP self-glucosylating protein
- Figure 3 shows the new pathway of starch synthesis in maize endosperm.
- UDPGppase UDP-glucose pyrophosphorylase
- ADPGppase ADP-glucose pyrophosphorylase
- BSS bound starch synthase
- SSSynthase soluble starch synthase
- BE branching enzyme
- Starch (amylose and amylopectin) will be synthesized only where the initiator protein (primer) is present and in amounts corresponding to the amount of primer. Amylogenin may determine how much starch is laid down and where it is laid down. It is therefore possible to genetically manipulate the starch content of plants by altering the level and distribution of amylogenin. The genetic manipulation of starch-bearing plants of commercial importance, particularly cereals such as maize, may result in new strains that are advantageous either for direct food uses, or other uses of starch, or as sources of starch to be used as a chemical feedstock.
- the ratio of amylose and amylopectin in corn starch may be altered which would create starches of considerable utility because of the diverse properties endowed on the different starches as thickening agents, edible food wrapping, etc.
- This route to new plant varieties complements the traditional and empirical processes of plant breeding.
- the basic technology is of potential" application to the manipulation of any storage polysaccharide and includes the possibility to suppress polysaccharide synthesis, as well as to enhance it, thereby altering the carbohydrate profile of the plant in directions that may be more favourable for nutritional or industrial uses.
- the method according to the invention is generally applicable to all plants producing or storing starch.
- the recipient plant may be: a cereal, in particular members of the family Gramineae such as maize (corn), wheat, rice, sorghum or barley; a fruit-producing species such as banana, apple, tomato or pear; a root crop such as cassava, potato, yam or turnip; an oilseed crop such as rapeseed, canola, sunflower, oil palm, coconut, linseed or groundnut; a meal crop such as soya, bean or pea; or any other suitable species.
- a cereal in particular members of the family Gramineae such as maize (corn), wheat, rice, sorghum or barley
- a fruit-producing species such as banana, apple, tomato or pear
- a root crop such as cassava, potato, yam or turnip
- an oilseed crop such as rapeseed, canola, sunflower, oil palm, coconut, linseed or ground
- Each donor gene encodes a starch primer (a protein molecule capable of initiating starch synthesis).
- the primer may be amylogenin and/or glycogenin, including amylogenin of plant origin and/or glycogenin or protoglycogenin of bacterial origin and/or glycogenin of fungal origin and/or glycogenin of animal origin.
- a donor gene may be derived from any suitable source including a plant, a bacterium, a fungus or an animal cell.
- suitable sources of plant genes include plants of the species Zea mays, Zea diploperennis, Zea luxurians, Zea perennis, Zea tripsacum, Zea parviglumis, Zea exicana or teosinte.
- a donor gene may be incorporated into the recipient plant genome by sexual crossing of the recipient plant and a sexually compatible donor plant.
- a donor gene may be isolated and then incorporated into the recipient plant genome by genetic transformation.
- the donor gene may be derived from cDNA or genomic DNA (gDNA) encoding a starch primer, or it may be synthesised ab initio using standard techniques. Typically the donor gene encodes the complete primer in the sense orientation so that the transcription product (mRNA) can be translated into the active starch primer enzyme. Alternatively, the donor gene may encode a portion of the starch primer in the sense orientation or may encode some or all of the primer in the antisense orientation so that the transcribed mRNA inhibits expression of the primer enzyme. It is possible to insert more than one copy of the donor gene into the recipient genome. At least one of the donor genes may encode a modified allelic form of the starch primer enzyme having altered characteristics (such as increased or decreased activity, or differing interactions with other enzymes) .
- the recipient plant's starch synthesising ability may be altered in various ways depending on the particular donor gene(s) which are incorporated.
- the total amount of starch produced (starch yield) may be increased or decreased; the rate of starch synthesis may be increased or decreased; the starch produced may have an altered structure; the ratio of amylose to amylopectin may be altered; the temperature optimum of starch synthesis may be increased or decreased; the capacity to produce starch at an elevated or lowered temperature may be improved.
- starch primer enzyme(s) For example, interaction of the starch primer enzyme with other starch synthesising enzymes (such as soluble starch synthase or branching enzyme) may affect the degree, rate and/or type of starch production.
- possible methods include: (1) Increasing the amount of the starch primer enzyme(s) in a recipient plant by the insertion of one or more additional copies of a normal donor gene encoding the primer(s).
- the source of these additional copies may be the recipient line itself as the technique would simply increase the amount of enzyme available in the grain rather than change of the properties of the enzyme(s).
- the gene promoters and other regulatory sequences may also be modified using known techniques to achieve increased amounts of the enzyme in the recipient plant: increased gene expression may be elicited by introducing multiple copies of enhancer sequences into the 5'-untranscribed region of the donor gene. (2) Insertion of one or more donor genes encoding a starch primer enzyme with enhanced activity.
- a source of the enhanced activity enzyme gene Such a source need not be a sexually compatible species as donor genes may be introduced using genetic manipulation techniques. Genetic material may thus be obtained from any source having a primer enzyme with the desired activity characteristics. Exogenous genetic material may alternatively be engineered to give the desired characteristics to the enzymes. Techniques are known in so-called "protein engineering" which can alter the characteristics of an enzyme.
- the invention further provides a plant having at least one donor gene encoding a starch primer stably incorporated into the plant's genome such that the plant's ability to synthesise starch is altered.
- the starch primer may be amylogenin and/or glycogenin.
- Presence of the donor gene(s) encoding a starch primer alters the natural process of starch production in the plant. It may alter the rate of starch production, the starch yield, the structure of the starch produced and so on. For example, such transgenic plants may have an increased capacity to produce starch and so are capable of producing higher yields and/or are capable of producing starch at a faster rate.
- the alteration may be an indirect effect: for example, presence of the donor gene(s) may change the natural expression ratios of the enzymes in the starch biosynthetic pathway leading to altered starch synthesis, including a different amount of starch or a different branching pattern in the starch.
- the invention also provides DNA encoding amylogenin and/or glycogenin.
- Suitable cDNA or gDNA clones may be isolated from cDNA or gDNA libraries using standard cloning techniques. These cDNA or gDNA clones may then be used as probes ' for equivalent genes in other species, particularly starch-producing organisms.
- the enzyme amylogenin may be isolated by subjecting a crude plant extract containing the enzyme (eg maize endosperm) to successive purification by gel chromatography. Antibodies to the substantially pure amylogenin protein may be produced. Such antibodies may be used to screen cDNA libraries for the identification of amylogenin clones.
- a cDNA clone encoding amylogenin was deposited at the American Type Culture Collection, 12301 Parklawn Drive, Rockville, Maryland 20852, USA under the terms of the Budapest Treaty on 19 August 1993 under the accession number ATCC 69389.
- amylogenin and/or glycogenin DNA clones may be used to alter starch production and starch quality in plants by the method described above.
- DNA encoding amylogenin and/or glycogenin may be transferred into plants by sexual crossing or by transformation.
- a tran ⁇ genic maize plant containing an amylogenin DNA clone may have increased starch yield.
- a transgenic maize plant containing anti-sense DNA clones may have decreased starch yield but increased sugar content.
- the DNA clones may also be used to express the enzyme amylogenin and/or glycogenin in a biological organism such as E coli.
- Figure 1 shows the biochemical pathway of starch biosynthesis in leaves.
- Figure 2 shows the biochemical pathway of starch biosynthesis in storage tissues.
- FIG. 3 shows the new biochemical pathway of starch biosynthesis in storage tissues.
- Figure 4 shows the proposed mechanism of glycogen synthesis.
- Figure 5 shows a model for the mechanism of glycogen biogenesis in muscle.
- FIG. 6 shows the separation of sweet corn amylogenin (SGP) on DEAE-Sepharose.
- FIG. 7 shows the fractionation of sweet corn amylogenin (SGP) on Sepharose C1-6B.
- FIG. 8 shows the separation of prelabelled amylogenin (SGP) on Sepharose C1-6B.
- Figure 9 shows the refractionation of the combined amylogenin (SGP)-containing fractions.
- the first step in the biogenesi ⁇ of glycogen involve ⁇ the covalent attachment of glucose to Tyr 194 in glycogenin by a protein tyrosine glucosyltran ⁇ ferase that has yet to be identified.
- the glucosyl-glycogenin so formed is autocatalytic and extends the covalently attached glucose into a maltosaccharide chain by adding another seven glucose units to itself.
- Maltooctaosyl-glycogenin then prime ⁇ the ⁇ ynthesis of proglycogen (Mr 400kDa) by proglycogen ⁇ yntha ⁇ e and branching enzyme.
- glycogenin itself fulfills this role and catalyze ⁇ the gluco ⁇ ylation of Tyr 194 before proceeding to elongate the initial glucose unit into a alto ⁇ accharide chain. While the nascent glucose may be extended into a chain of eight glucose residue ⁇ , proglycogen synthase may act before the chain has reached its full length.
- the maltooctaose unit that is constructed on glycogenin after undergoing complete self-glucosylation may not be a prerequi ⁇ ite for the priming of proglycogen ⁇ ynthe ⁇ is and chains of smaller lengths also may serve as the glucan primer.
- proglycogen syntha ⁇ e al ⁇ o The identity of proglycogen syntha ⁇ e al ⁇ o remains to be determined. Whether it is a distinct enzyme or a form of glycogen synthase with a specificity for proglycogen has to be elucidated. If the latter i ⁇ the ca ⁇ e, then the manner in which it differ ⁇ from cla ⁇ sical glycogen synthase will be interesting to examine and may provide additional clues to understanding the intricate regulation of glycogen metabolism.
- the protein primer model for the biogenesi ⁇ of mammalian glycogen may extend to ⁇ tarch ⁇ ynthe ⁇ is and perhaps to polysaccharide synthe ⁇ i ⁇ in general. Simple tests u ⁇ ing an antibody to glycogenin have indicated that glycogenin-like material may be present in vertebrates, invertebrates, plants, yeast, fungi and bacteria containing glycogen and ⁇ tarch (Gieowar-Singh et al, 1988, FASEB J, 2(1518) :A557) .
- the pre ⁇ ence of glycogenin-like protein ⁇ in a wide variety of lifeform ⁇ ⁇ ugge ⁇ t that ⁇ imilar protein-priming mechani ⁇ m ⁇ for poly ⁇ accharide synthesi ⁇ may be occurring in the ⁇ e species.
- the priming mechani ⁇ m for ⁇ tarch biosynthesis had hitherto not been elucidated and the nature of the priming molecule ij vivo remained unknown. However, the present evidence points to a protein primer.
- the enzyme that catalyzed the glucosylation wa ⁇ referred to as UDPglucose protein transgluco ⁇ yla ⁇ e 1 and it functioned at micromolar concentration ⁇ of UDPgluco ⁇ e.
- the glucosylated protein serves a ⁇ a primer for the formation of protein-bound alpha, 1-4 gluco ⁇ idic chain ⁇ by accepting gluco ⁇ e units tran ⁇ ferred from UDPglucose, ADPglucose or gluco ⁇ e 1-pho ⁇ phate. It was proposed that the chain elongation, which occured in the presence of millimolar concentrations of the glucose donor, was catalyzed by the endogenous starch synthase or phosphorylase in the preparation.
- the protein undergoing glucosylation in the first step had a molecular weight of 38kDa and the added glucose was resistant to hydrolysis by alpha- and beta-amylase.
- Glucoa ylase was capable of hydrolysing the protein-bound glucose which was ⁇ ub ⁇ equently identified by paper chromatography.
- the added glucose underwent beta-elimination upon alkaline treatment in the presence of sodium borohydride and was thereby converted to sorbitol a ⁇ determined by paper electrophore ⁇ is.
- Tritiated alanine and tritiated 2- aminobutyric acid expected by H-sodium borohydride reduction of the 2-amino acrylic acid and 2-amino crotonic acid generated by beta- elimination of carbohydrate ⁇ attached to ⁇ erine and threonine residues, were both obtained. Therefore, both serine and threonine re ⁇ idue ⁇ ⁇ eemed to be involved in the linkage to gluco ⁇ e.
- UDPglucose, ADPgluco ⁇ e or gluco ⁇ e 1-phosphate was then added to the incubation mixture in millimolar concentrations as substrates for the endogenous chain-lengthening glucosyltransfera ⁇ es in the potato tuber preparation.
- the gluco ⁇ yltran ⁇ ferase activities that catalyzed the chain extension of the 38kDa glucosylated acceptor protein had copurified with the first phosphorylase peak which was used to reconstitute the ⁇ ynthesis of protein-bound alpha, 1-4 glucan. Chain extension was demonstrated by the increase in the molecular weight of the 38kDa radioglucosylated acceptor protein on SDS-PAGE and fluorography.
- the chain lengthening enzymes contained in the first phosphoryla ⁇ e peak utilized UDPgluco ⁇ e, ADPgluco ⁇ e and gluco ⁇ e 1-pho ⁇ phate a ⁇ gluco ⁇ yl donors.
- Major radiolabelled bands at 43kDa and 50kDa were observed on 12.5% acrylamide gel ⁇ when UDPgluco ⁇ e and ADPglucose were used as chain- lengthening substrates.
- glucose 1-phosphate was used, only the 50kDa labelled band was obtained with the 12.5% gel, which migrated as a 70kDa species on a 10% gel.
- the 70kDa species following exci ⁇ ion and elution from the gel, wa ⁇ partially converted to a ⁇ pecie ⁇ of 38kDa upon treatment with beta amyla ⁇ e.
- Thi ⁇ ⁇ upported the contention that the 70kDa ⁇ pecies, or at least part of it, originated from the 38kDa glucosylated acceptor protein and was synthesized as the latter underwent chain elongation by the addition of alpha, 1-4 gluco ⁇ e moieties.
- the gluco ⁇ yltransferase and the acceptor protein copurified to homogeneity demonstrating that both were one and the ⁇ ame protein.
- the glucosyltransferase i ⁇ an autocatalytic enzyme that undergoe ⁇ self-glucosylation to form the protein primer required for alpha, 1-4 glucan synthesis in the potato tuber.
- a similar autocatalytic glycosyltran ⁇ ferase with a molecular weight of 40kDa has been purified from Daucu ⁇ carota L (carrot) cells.
- the enzyme functions in micromolar concentration ⁇ of UDPglucose from which it tranfers glucosyl moieties onto itself.
- Treatment of the radioglucosylated product with weak alkali (0.1N NaOH, 24°C, 24hr) and strong alkali (IN NaOH/lM NaBH 4 , 100°C, lOhr) partially ⁇ eparated the carbohydrate from the protein.
- Methylation of the oligo ⁇ accharides so released produced 2,3,4,6 tetra-O-methyl-glucitol- acetate as the only labelled carbohydrate indicating that autoglucosylation added only one gluco ⁇ e residue to the protein.
- the enzyme also utilized UDPgalacto ⁇ e as a sub ⁇ trate undergoing autogalactosylation. While thi ⁇ carrot enzyme i ⁇ ⁇ imilar to the autocatalytic protein that appears to prime alpha, 1-4 glucan synthe ⁇ i ⁇ in the potato tuber it has yet to be implicated in polysaccharide biogenesis.
- beta-glucans al ⁇ o appear ⁇ to proceed through a glycoprotein intermediate.
- the formation of protein-linked oligo ⁇ accharide ⁇ that ⁇ eemed to be involved in the ⁇ ynthesis of beta- glucans was detected in bacteria, fungi, algae and higher plants.
- the evidence that a glycoprotein primed beta-glucan synthesis in these studies was circumstantial and a covalent linkage between a beta-glucan chain and a protein was never demonstrated.
- Chlorophyta Prototheca Zopfii algae
- the evidence is more convincing that beta- glucan synthe ⁇ i ⁇ i ⁇ initiated on a protein primer.
- the double-labelled glycoprotein intermediate was resistant to beta-elimination (0.15M NaOH, IM NaBH., 100°C, 5hr) indicating that the carbohydrate moiety was not. linked by an O-glycosidic bond to serine/threonine or by an N-glycosidic bond to asparagine.
- Treatment with saturated barium hydroxide (0.2M Ba(OH) 2 , 100°C, 6hr) liberated a double-labelled aminoacyl- oligo ⁇ accharide from the glycoprotein.
- the ⁇ ource of the amylogenin enzyme (or ⁇ elf- glucosylating protein, SGP) was a US inbred line (B73) of Zea mays.
- the kernels were cut from the cobs directly into a food grinder which functioned by continuously extruding the ground material.
- the ground kernels were collected and expressed through cheese cloth into a beaker surrounded by ice and containing a concentrated extracting solution which, after dilution by the corn juice, gave a final concentration of 50mM Tris-HCL pH 7.4, 5mM EDTA (ethylene diamine tetra acetate), O.lmM EGTA, 14mM mercaptoethanol, O.lmM PMSF
- the amount of concentrated extracting solution needed for each preparation was estimated at the outset.
- the exact volume of the extract could not be predetermined because of variability in the size of the cob ⁇ . Therefore, an average volume of 70ml of extract/cob was used for e ⁇ timating the amount of concentrated extracting solution required. After the final volume of the mixture was measured, the quantity of extracting solution was adjusted to give the desired concentration.
- the use of a concentrated extracting solution facilitated in keeping the volume of the extract to a minimum, which from a typical preparation with 15 cobs of corn, ranged between 1100-1300 milliliters.
- the filter was placed in 4ml of scintillation liquid (Ecolume) and measured for 14C radioactivity in a Searle Delta 300 6890 liquid scintillation counter.
- Ecolume scintillation liquid
- the radioactivity measured on the filter represents 14C-glucose that was incorporated into
- TCA-precipitable material (assuming no conversion to the glucose molecule into any other compound).
- the assay provides a means of quantitating
- the assay also detects, in a crude extract, the incorporation of radioactivity into a TCA-precipitable, lipid-like substance.
- This lipid-like substance is soluble in methanol, methanol/chloroform and ethanol.
- this lipid-like substance represent ⁇ about 80-90% of the TCA-precipitable, radiolabelled material measured by the as ⁇ ay.
- a ⁇ SGP is purified away from this sub ⁇ tance, however, the assay provides an accurate mea ⁇ urement of SGP activity.
- the blot was washed 3 times with Tris-buffered ⁇ aline (TBS) and then incubated overnight in TBS containing 1% gelatin with goat anti-glycogenin IgG (1:1000 dilution of original stock). Next, the blot was washed 3 times with TBS and then incubated with alkaline phosphatase-conjugated rabbit anti-goat IgG. The antigen-bound protein bands were detected by color development with solutions of BCIP (5- bromo-4-chloro-3indolyl phosphate) and NBT (p- nitroblue tetrazoliu chloride) a ⁇ in ⁇ tructed by the ⁇ upplier.
- BCIP bromo-4-chloro-3indolyl phosphate
- NBT p- nitroblue tetrazoliu chloride
- Radioautography wa ⁇ performed on dried gel ⁇ , immunoblot ⁇ and thin layer ⁇ ilica plate ⁇ containing radiolabelled material ⁇ by expo ⁇ ure to Kodak X-OMAT XAR-5 film ⁇ at -70°C. (Fluorography was also performed on dried gels in the same manner). The films were developed with an automated Kodak X-OMAT film processor. 24
- Step 2- Fractionation by ⁇ alt precipitation Solid ammonium ⁇ ulphate was added to the pH 5.0 supernatant to give a 50% saturated ⁇ olution. Protein was allowed to precipitate overnight and collected by centrifugation at 10,000 x g. The protein pellet was resuspended in 50mM Tris-HCL pH
- the dialyzed solution wa ⁇ applied to a DEAE- Sepharo ⁇ e column (6 x 15cm) that was equilibrated with TC. After pas ⁇ ing equilibrating buffer through the column to remove unbound material, the protein was desorbed with an increasing concentration gradient of NaCl, from 0 to IM, formed from 500ml 25
- the concentrated material was applied, in two equal portions during separate runs, to a Sepharose Cl 6B column (3 x 85cm) that wa ⁇ equilibrated with TC and eluted with the ⁇ ame buffer (Figure 7).
- the protein-gluco ⁇ ylating activity was found in a single, but broad, peak that began at the void colume.
- the material that emerged at the front7 represented a single protein specie ⁇ on a ⁇ ilver- ⁇ tained gel after SDS-PAGE and po ⁇ e ⁇ ed aoth the gluco ⁇ ylating activity and the glucosylation site.
- the ⁇ e early fraction ⁇ containing homogenou ⁇ protein represented about 10% of the total glucosylating activity applied to the column.
- the later fractions contained more activity but were increasingly less pure with each additional fraction.
- Pha ⁇ e 1 Partial purification of the self- glucosylating protein and subsequent prelabelling by autoglucosylation:
- Step 3 Fractionation by ion exchange chromatography.
- Steps 1-3 are exactly the first three step ⁇ in the protocol for purifying active SGP ( ⁇ ection 2.3) and were carried out in the ⁇ ame manner. Following the fractionation on DEAE-Sepharose and concentration of the SGP containing fractions, the enzyme was allowed to undergo self-glucosylation, 25% with UDP-[ 14C]glucose and the remaining 75% with unlabelled UDPgluco ⁇ e. The prelabelled protein wa ⁇ then purified further.
- the incubation mixture wa ⁇ applied to a Sepharose C1-6B column (3 x 85cm) equilibrated with 50mM Tris-HCL pH 7.4 buffer containing 0.02% triton and eluted with the same buffer (Figure 8). Fractions were collected in a volume of 5.5ml each.
- the prelabelled SGP was detected by measuring lOOul aliquot ⁇ from alternating fraction ⁇ for 14C- radioactivity.
- the prelabelled protein emerged in a broad peak similar to that observed for the native unglucosylated enzyme.
- a peak of 14C-radioactivity detected at the total volume of the column repre ⁇ ented unreacted radiolabelled UDPgluco ⁇ e from the prelabelling reaction.
- the protein was desorbed from the column with linear gradient ⁇ of acetonitrile generated by u ⁇ ing 0.1% TFA (trifluoroacetic acid) in water ( ⁇ olution A) and 0.09% TFA in water containing 84% acetonitrile (solution B) at a flow rate of lml/min.
- the first two separations were performed successfully with a linear gradient of 0-100% solution B applied over a period of 50 minutes followed by an additional 10 minute ⁇ with 100% ⁇ olution B.
- further separations were carried out with a gradient composed of the following linear segments : 0-30 minutes, 0-70% solution B; 30-31 minutes, 70%-100% solution B; 31- 41 minutes, 100% solution B.
- the altered gradient worked with the same successive ⁇ . Protein wa ⁇ detected by monitoring the ab ⁇ orbance of the effluent at 30
- Peaks containing protein were collected manually and the prelabelled SGP emerged from the column in a single peak.
- the fractions containing prelabelled SGP from each run were pooled together.
- the combined fractions had a volume of 10.7ml and was concentrated to approximately half its volume on a ⁇ peed-vac.
- the concentrated ⁇ ample was then diluted to its original volume with water thereby reducing its acetonitrile concentration by approximately half.
- the sample wa ⁇ then refractionated on the C, column in two portion ⁇ ( Figure 9).
- 5.7ml of the sample was applied to the column by injecting consecutively six aliquot ⁇ of 950ul each.
- the remainder of the ⁇ ample wa ⁇ fractionated in a ⁇ econd run by injecting five 950ul aliquot ⁇ onto the column.
- Step 1 Reduction with DTT (20 umol/mg protein) .
- Step 2 Carboxymethylation with iodoacetic acid (60 umol/mg protein).
- Step 3 Reduction with DTT (30 umol/mg protein) .
- Step 4 Carboxymethylation with iodoacetic acid (60 umol/mg protein).
- the reaction was terminated by adding 17.5ul of 1.0M DTT to the incubation mixture.
- the protein wa ⁇ dialyzed against 50mM Tris HCL pH 7.6 buffer containing ImM CaCl 2 on a Pierce Microdialysi ⁇ System 500.
- the progre ⁇ of dialy ⁇ is was monitored by following the decrea ⁇ e in conductivity of the ⁇ ample. This was achieved by taking 2.5ul aliquot ⁇ from the sample at regular intervals and, after diluting in 10ml of water, measuring the conductivity. Dialysis was stopped after a 100 fold decrease in conductivity was obtained over 2.5 hr. After dialysis, the volume of the sample had increased to 550ul and its pH was 7.8. 3.
- the proportion of each amino acid in the two protein ⁇ are comparatively ⁇ imilar.
- the ratio of glycine, arginine, alanine, and valine in each protein differ by le ⁇ s than 10% while that of leucine, phenylalanine and lysine are less than 13% different.
- the sample of purified prelabelled SGP contained 149.2ug of protein.
- it wa ⁇ found that the partially pure protein wa ⁇ re ⁇ i ⁇ tant to trypsinoly ⁇ i ⁇ with 70% proteoly ⁇ is occurring over a 48 hr incubation period.
- reduction and carboxymethylation wa ⁇ performed.
- the protein wa ⁇ then digested with trypsin in an enzyme/sub ⁇ trate ratio of 1:25 for 15 hr.
- the radiolabelled peptide T2 is a proteolytic fragment ' of the larger radiolabelled peptide T6. It is likely therefore that the radiolabelled peptide in P8 wa ⁇ ⁇ imply a larger peptide comprising T2 and T6 formed from incomplete proteolysis. The emergence of the peptide later than T2 and T6 ⁇ uggest that it has a larger size. The small quantity of radioactivity (12000cpm) further suggest that the peptide may have arisen from incomplete hydrolysis and more ⁇ o that trypsinolysis was performed for only 15 hr.
- the peptide T2 was submitted to ion-spray mass spectrometry in order to determine it ⁇ preci ⁇ e molecular mass.
- the ion-spray ma ⁇ s spectrum of the peptide yielded only one prominant signal at m/z (mass/charge ratio) 888.9 corresponding to a molecular mass of 1777.8 Da for a doubly protonated ion.
- the molecular mas ⁇ of peptide T2 calculated from it ⁇ amino acid composition by assuming an arginine residue in po ⁇ ition 7 i ⁇ 1776.97.
- the ⁇ ignal mu ⁇ t represent peptide T2 and in combination with the amino acid analysis data confirms that the amino acid to which the glucose is attached at position 7 is arginine. It should be noted that minor signal ⁇ were ob ⁇ erved in the ion spray mass spectrum. These may repre ⁇ ent contaminants in the ⁇ ample a ⁇ well as sodium and potassium salts of the peptide.
- the major ⁇ ignal represent ⁇ the doubly protonated parent ion corre ⁇ ponding to the gluco ⁇ ylated peptide T2.
- the minor signal is due to a doubly charged daughter ion generated by fragmentation of the parent ion.
- the mass difference between the parent ion and the daughter ion is 163 Da which corresponds to a glucosyl fragment.
- the protein was digested with trypsin to generate peptides for ⁇ ub ⁇ equent ⁇ equencing.
- trypsin modified by reductive alkylation (Promega) was used.
- the modified trypsin is extremely resi ⁇ tant to autolytic digestion.
- the lyophillized TPCK- treated, modified trypsin was dissolved first in 50mM acetic acid to a concentration of lug/ul. Fifteen microliters (15ul) of this ⁇ olution was added to the sample containing 144ug of purified SGP in a volume of 530ul giving a protease : protein ratio of 1 : 25 (w/w) .
- the digest was incubated at 37 ⁇ C for 15 hr.
- the peptides generated by trypsinolysis on purified SGP were isolated by reverse-phase HPLC on a Perkin Elmer HPLC sy ⁇ tem using a Vydac C, « column (100 x 4mm). At the end of proteoly ⁇ is the whoie digest was applied to the column. Peptides were eluted with a linear gradient between 0.1% TFA in water ( ⁇ olution A) and 0.09% TFA in water containing 84% acetonitrile (solution B) applied over a period of 100 min at a flow rate of 0.4ml/min. Peptides were detected by monitoring the absorbance of the effluent at 215nm and 295nm ⁇ imultaneou ⁇ ly and collected manually.
- Amino acid sequence analy ⁇ e ⁇ were performed by the Edman degradation procedure on an Applied Bio ⁇ y ⁇ tem ⁇ 470A gas-phase ⁇ equencer equipped with an on line model 120 phenylthiohydantoin analyzer using the 03R phenylthiohydantoin standard program.
- Ion-spray mass spectrometry and ion-spray tandem mass spectrometry were performed on the radioglucosylated tryptic peptide isolated from purified prelabelled SGP.
- the ion-spray mass spectra and ion-spray tandem mass spectra were recorded on a Sciex (Toronto) API 111 triple- quadrupole ma ⁇ s spectrometer with 2400-Da mas ⁇ range equipped with an ion spray source.
- the mas ⁇ spectrometer was operated under unit-ma ⁇ re ⁇ olution conditions for all determinations.
- the ion spray voltage was 5kV.
- the samples were dissolved in 1% formic acid/methanol prepared in a 1 : 1 (vol/vol) ratio and introduced into the ion spray source at a constant flow rate of 5ul/min with a microliter syringe by using a medical infusion pump (Harvard
- Argon at a target gas thickness of approximately 1.2 x 10 14 atoms per cm2 was used as collision gas for tandem mass spectrometry.
- the collision energies ranged from 40 to 60 eV.
- the self-glucosylating protein in rabbit muscle, as isolated, contain ⁇ at least one glucose unit. Self-glucosylation consi ⁇ ts in lengthening this chain to eight units by the addition of 1,4- linked alpha-glucose residues. The added glucose 41
- the first step was to determine whether the radioactivity incorporated into the SGP wa ⁇ in fact radiolabelled gluco ⁇ e and not a byproduct of a conversion reaction.
- SGP was allowed to undergo radiolabelling and then acid hydrolysis performed on the product.
- An autoradiograph of the hydrolysate after thin layer chromatography included a radiolabelled gluco ⁇ e standard. Under mild hydrolysi ⁇ , after boiling in 2M trifluoroacetic acid for 30 minute ⁇ , a faint radiolabelled band i ⁇ seen at the position of gluco ⁇ e.
- three ⁇ lower moving radiolabelled bands of stronger intensity were observed. Under stronger conditions, by boiling for 2 hrs, the ⁇ ame radiolabelled band ⁇ are ob ⁇ erved.
- the radiolabelled band at the po ⁇ ition of glucose was much more intense and the two other band ⁇ had a ⁇ lightly le ⁇ inten ⁇ ity than before.
- the appearance of the radiolabelled band at the gluco ⁇ e marker after acid hydrolysis indicates that the radioactivity incorporated into SGP is radiolabelled glucose.
- the incorporated glucose was not bound by an acid labile bond since strong acid hydrolysi ⁇ was necessary to release a ⁇ ignificant amount of the carbohydrate from the protein. It is unclear what the slower moving radiolabelled bands represent, but perhaps these may be radiolabelled peptide fragments from the protein.
- the radiolabelled glucose attached to SGP after undergoing radioglucosylation is not removable by glycogenolytic enzymes, namely alpha- amylase, beta-amylase and glucoamyla ⁇ e. It is removable, however, by beta-glucosida ⁇ e.
- glycogenolytic enzymes namely alpha- amylase, beta-amylase and glucoamyla ⁇ e. It is removable, however, by beta-glucosida ⁇ e.
- beta-glucosida ⁇ e When a ⁇ ample wa ⁇ incubated with beta-gluco ⁇ idase only 50% of the radiolabelled glucose was removed, and only after 72 hr of digestion.
- the difficulty in hydrolysing the glucose by beta-glucosida ⁇ e suggested that there may be steric hindrance to the enzyme. Therefore, it wa ⁇ decided to te ⁇ t the beta- gluco ⁇ ida ⁇ e on a prelabelled tryptic peptide.
- Alpha-Glucosida ⁇ e failed to remove any glucose from the ⁇ ame glucopeptide and in the intact prelabelled
- alpha-amyla ⁇ e, beta-amylase and glucoamyla ⁇ e were not attached to the protein.
- the removal of the gluco ⁇ e by beta-gluco ⁇ ida ⁇ e indicate ⁇ that it is attached via a beta-linkage.
- a sample of prelabelled SGP from sweet corn was prepared by allowing the enzyme to undergo self glucosylation with UDP-[ 14C]gluco ⁇ e.
- Thi ⁇ wa ⁇ accomplished by incubating 250ul of a 16 fold purified sample of the protein with 50mM Tris-HCl pH 7.4 buffer, 5mM MnCl 2 and 2uM UDP-[ 1 C]gluco ⁇ e in a 500ul reaction mixture at room temperature for
- a sample of prelabelled SGP from sweet corn wa ⁇ prepared. Five hundred microliters (500ul) of a 16 fold purified sample of the protein was allowed to self glucosylate with UDP[ 14C]gluco ⁇ e in a lOOOul reaction mixture. The prelabelled SGP ⁇ o formed was used in the following digestion ⁇ .
- This experiment was performed as a control for the glycosidase digestion of prelabelled sweet corn SGP.
- a ⁇ ample of prelabelled SGP from rabbit mu ⁇ cle was prepared in a similar manner to that from sweet corn. Two hundred microliters (200ul) of a 20 fold purified sample of the muscle enzyme was allowed to undergo autoglucosylation in a 400ul reaction 46
- the prelabelled muscle SGP was incubated with glycogenolytic enzymes in the following digestions.
- the precipitate was filtered on nitrocellulo ⁇ e, washed and measured for 14C radioactivity.
- Prelabelled SGP was prepared from 500ul of al6 fold purified ⁇ ample of the enzyme in a lOOOul reaction mixture and u ⁇ ed for the following digestion ⁇ . 47
- a radiolabelled tryptic peptide was prepared from prelabelled SGP, obtained with a 16 fold purified sample of the enzyme in the following manner. Three hundred microliter ⁇ (300ul) containing 25400cpm of the prelabelled protein was precipitated with an equal volume of 20% TCA and collected by centrifugation. After washing the pellet twice with ether, it was dissolved in 50ul of 8M urea containing 0.4M ammonium bicarbonate at pH 8.0. The sample was heated at 55°C for 15 min 48
- TPCK-trypsin (Pierce) was then added to the sample to give a 1 : 25 protease : protein ratio and incubated at 37°C for 24 hr. Following this, the same amount of trypsin was added again and the sample incubated for a second 24 hr period.
- the enzyme has a double pH optima. Furthermore, the enzyme is about 3 times more active at pH 8.5 than at pH 4.5.
- the extract that inhibit ⁇ both the self- gluco ⁇ ylating protein and the lipid-gluco ⁇ ylating activity. Furthermore, the inhibitor is stable to heat as a heated extract inhibits the glucosylating activity in a dialyzed extract.
- ATP was found to be a potent inhibitor to the ⁇ weet corn SGP.
- ATP is a 30-fold more potent inhibitor of sweet corn SGP with 50% inhibition occuring at a concentration of lOOuM.
- the self-glucosylating protein in rabbit muscle is inhibited by p-nitrophenyl-saccharides, namely p-nitrophenylglucose, p-nitro- phenylmalto ⁇ e, p-nitrophenylmaltotrio ⁇ e and p- nitrophenyl- maltotetrose.
- These synthetic compound ⁇ inhibit by acting as alternative substrates.
- the rabbit muscle SGP function ⁇ by tran ⁇ ferring glucose from UDPglucose to a pre- exi ⁇ ting oligo ⁇ accharide chain attached to it ⁇ elf via tyrosine, extending the chain to eight glucose unit ⁇ long.
- the ⁇ e p-nitrophenyl ⁇ accharides by mimicking the acceptor site, can act as acceptors for the tran ⁇ ferred gluco ⁇ e.
- thi ⁇ behaviour of the p-nitrophenylsaccharides further demonstrates the function of rabbit muscle SGP in synthe ⁇ izing alpha-1,4 gluco ⁇ idic bond ⁇ .
- p- Nitrophenol, p-nitrophenyl-alpha-glucoside and p- nitrophenyl-beta-glucoside were tested on sweet corn SGP and no effect on its activity was observed. This observation indicated that there was a fundamental difference in the self- 52
- glucosylating activity between the muscle and sweet corn proteins were examined for any inhibitory effect on the activity of the sweet corn SGP. No effect was observed, indicating that the enzyme is unable to utilize these as sub ⁇ trate ⁇ .
- Sweet corn SGP i ⁇ completely dependent on divalent cation ⁇ for it ⁇ activity.
- the sweet corn SGP looses all it ⁇ activity.
- the concentration dependence of sweet corn SGP on various divalent cations was measured.
- Manganese has the most potent stimulating effect at a concentration of 5mM. Magnesium also activated SGP but to a les ⁇ er extent than manganese, achieving a maximum stimulating effect of about 50% at lOmM concentration. Calcium had no stimulatory effect on SGP activity.
- Radioglucosylation in the absence of MnCl 2 When a cell-free extract is assayed for SGP in the absence of Mn ion, in addition to the SGP, a number of proteins of higher molecular weight became radiolabelled. Of these, the most prominent radiolabelled band occurs in the region of approximately 70kDa. This form of apparent radioglucosylation occurs within the 30 min incubation period allowed for the SGP assay. The activity, however, was pre ⁇ ent only ⁇ ometimes and in most preparations was ab ⁇ ent. 3 -3
- radioglucosylation has been detected with partially purified extracts (16 fold) in which proteins of molecular weight higher than SGP become radiolabelled in the absence of manganese ions.
- this form of radiogluco ⁇ ylation i ⁇ detectable only after prolonged incubation and occur ⁇ over a 24 hr period.
- the reaction proceed ⁇ in the pre ⁇ ence of ImM MnCl 2 but is inhibited by 5mM of the divalent cation.
- UDPglucose as well as ADPglucose serve as sub ⁇ trate ⁇ for the reaction.
- Thi ⁇ i ⁇ unlike SGP which utilize ⁇ UDPgluco ⁇ e as a substrate but not ADPglucose.
- radiolabelled proteins formed during this 24 hr incubation period range in molecular weight between 42kDa and 200kDa and appear as sharp distinct bands on a radioautograph following SDS- electrophoresis. Evenly spaced radiolabelled bands appear between 42kDa and 70kDa separated by approximately 3kDa.
- the radiolabelled band ⁇ would represent SGP with different amounts of carbohydrate.
- the radiolabelled product ⁇ were incubated with glycogenolytic enzyme ⁇ in an attempt to remove the radiolabel from the protein ⁇ . It wa ⁇ found that the radiolabel wa ⁇ resistant to hydroly ⁇ i ⁇ by alpha-amyla ⁇ e, glucoamyla ⁇ e, phosphorylase and isoamyla ⁇ e. Con ⁇ equently the radiolabelled product ⁇ were incubated with cellula ⁇ e to determine whether the radioactive glucose was attached in a beta-linkage. Cellula ⁇ e 54
- the sweet corn SGP was the protein primer upon which the starch molecule wa ⁇ con ⁇ tructed, then it may be po ⁇ sible to synthesize starch in vitro by incubating the primer with the starch synthesizing enzymes, and the glucose donor ⁇ ub ⁇ trate ⁇ (UDPgluco ⁇ e and ADPgluco ⁇ e).
- the ⁇ ynthe ⁇ i ⁇ of ⁇ tarch on the protein primer could be detected by monitoring the increase in the molecular weight of the protein as the carbohydrate increases in size. Thi ⁇ could be accompli ⁇ hed by SDS-PAGE which can demonstrate any change in the molecular weight of the protein.
- the prelabelled protein therefore, was incubated with cell-free extracts of corn and millimolar concentrations of UDPglucose and/or ADPglucose. At different time intervals aliquots of the incubation mixture were analyzed by SDS-PAGE and radioautography. After 1 hr of incubation, the appearance of a radiolabelled band at the top of the gel occurred and this was also observed for 2 hr and 3 hr time periods. In addition, there was a decrease in the amount of radiolabel at 42kDa, the position of prelabelled SGP. The decrease in intensity of the SGP band was moreso at 2 hr and 3 hr.
- Prelabelled SGP for thi ⁇ purpo ⁇ e wa ⁇ prepared from a 16 fold purified extract by incubating a ⁇ ample of the enzyme with 2uM UDP-[ 14C]gluco ⁇ e, 5mM MnCl 2 and 50mM Tris-HCl pH 7.4 buffer at room temperature for 20 min. Following incubation, the reaction mixture was applied to a Sephadex G-25 column (6 x 1.5cm) equilibrated with 50mM Tris-HCl pH 7.4 buffer containing 2mM CHAPS and eluted with the same buffer. Fractions (1ml) were collected and the prelabelled SGP was detected by measuring 50ul aliquot ⁇ for C-radioactivity.
- the prelabelled SGP (typically about lOOOOcpm) was incubated with ImM UDPglucose or ImM ADPglucose or both and an equal volume of dialyzed or undialyzed sweet corn extract at room temperature in 1ml dige ⁇ ts. At 1 hr, 2 hr, 3 hr and 24 hr time intervals 250ul aliquots were taken and frozen to stop the reaction. The protein was precipitated with an equal volume of 20% TCA and collected by centrifugation. The pellets -were wa ⁇ hed twice with ether and dried.
- the dried pellets were des ⁇ olved in 50ul of ⁇ olubilizing buffer by incubation for 24 hr followed by ⁇ trong vortexing. SDS-PAGE were performed on lOul of the ⁇ ample followed by fluorography.
- SGP during development must precede or coincide with the on ⁇ et of starch production if the protein is a primer for starch synthe ⁇ is.
- the formation of SGP at a later time will certainly preclude it from any involvement in the biogene ⁇ is of starch. Therefore an examination of the formation of SGP during development, particularly the period during which the poly ⁇ accharide i ⁇ laid down in the cell, would provide con ⁇ iderable ⁇ upport for or against the hypothesi ⁇ that the protein i ⁇ a precursor of starch.
- pyrophosphorylase ATP-dependent fructokinase, ATP- dependent glucokinase, branching enzyme, bound ⁇ tarch synthase, ATP-dependent phosphofructokinase, PPI-dependent phosphofructokinase, phosphoglucomutase, soluble starch syntha ⁇ e, ⁇ ucrose synthase, UDPG pyrophosphorylase and UTP- dependent fructokinase were mea ⁇ ured in term ⁇ of enzyme concentration, a ⁇ unit ⁇ /endo ⁇ perm. The ⁇ e were expressed as a percentage of the maximum value measured. In addition, the starch content, dry weight of the endosperm, the number of endo ⁇ perm cell ⁇ , number of ⁇ tarch granules, the albumin content and concentration and the rates of starch accumulation were also determined.
- prelabelled self- glucosylating protein from B73 commercial dent corn was achieved in a 800 fold purification over the cell-free extract.
- the protein was partially purified in an active state by ⁇ uccessive precipitation ⁇ with acid and ⁇ alt followed by fractionation on DEAE-Sepharo ⁇ e.
- the 27 fold purified enzyme wa ⁇ allowed to undergo ⁇ elf-glucosylation and the prelabelled protein purified further.
- the prelabelled protein was purified by ⁇ uccessive fractionations on Sephadex S300, Mono Q and C 4 .
- the degree of purification and yield at each stage of the protocol is listed in Table 3. 60
- the purified protein had a ⁇ pecific activity of 3.5 x 10 cpm/mg protein. Only 25% of the gluco ⁇ e, however, wa ⁇ radiolabelled. Therefore the calculated ⁇ pecific activity of the B73 corn SGP with all the incorporated gluco ⁇ e being radiolabelled would be 1.4 x 10 cpm/mg protein. The ⁇ pecific activity of the radiolabelled glucose was 4.4 x 10 14cpm/mole of glucose. Thi ⁇ implied that the B73 dent corn SGP had incorporated 0.13 mole of gluco ⁇ e into each mole of protein.
- This phase of the purification was carried out in exactly the same manner as described for pha ⁇ e 1 in the purification of prelabelled SGP from ⁇ weet corn.
- the protein wa ⁇ partially purified and allowed to undergo autogluco ⁇ ylation, 25% with UDP[ C]gluco ⁇ e and the remaining 75% with unlabelled UDPgluco ⁇ e.
- the prelabelled protein wa ⁇ then purified further.
- the prelabelling reaction mixture was applied to a Sephadex S-300 column (2 x 60cm) equilibrated with 50mM Tris-HCl pH 7.4 buffer containing 0.02% triton and eluted with the ⁇ ame buffer. Fraction ⁇ of 3ml each were collected and the prelabelled SGP detected by measuring 50ul aliquots from 14 alternating fractions for C-radioactivity. The fraction ⁇ containing the prelabelled SGP were analyzed by SDS-PAGE and tho ⁇ e that ⁇ howed the highest protein purity were combined. The pooled fractions were concentrated by centrifugation u ⁇ ing centriprep-10 concentrator ⁇ .
- Step 5 Fractionation by fa ⁇ t protein liquid chromatograpy (FPLC) on Mono Q
- the prelabelled SGP wa ⁇ purified next by reverse-phase HPLC using a Vydac C 4 column (8 x
- Polyclonal antibodies to purified amylogenin were generated in goats by the procedure of Lomako et al (1988, FASEB J, 2:3097-3103). Sufficient protein to enable the immunisation was obtained by pooling the enzyme subunit i ⁇ olated as described above from a number of separate experiments. Antisera were prepared against the 39 kD amylogenin polypeptide. The antibodies were then tested for specificity to the amylogenin polypeptides.
- polyclonal antibody Two further types have been made. One was generated against rabbit-muscle glycogenin obtained from rabbit-muscle glycogen. The other was generated from three synthetic peptides coupled to bovine serum albumin using glutaraldehyde. The peptides were: GDAMVTDIEAADE REGANFVRGYPFSLR NLDFLEMWRPFFQP 03
- the antibodies produced above may be used to screen a maize endosperm cDNA library for clones derived from the mRNA ⁇ for amylogenin in an in vitro tran ⁇ cription/ tran ⁇ lation ⁇ y ⁇ tem.
- the cDNA library may al ⁇ o be ⁇ creened with oligonucleotide ⁇ equence ⁇ derived from the amino acid ⁇ equence of amylogenin. Numerous oligonucleotide probes have been synthesised.
- Double-stranded cDNA was prepared from oligo dT-cellulose-purified maize endosperm RNA by a method employing RNaseH and E coli DNA polymerase for the ⁇ ynthesis of the ⁇ econd ⁇ trand, without prior purification of ⁇ ingle-stranded cDNA (Gubler and Hoffman, 1983).
- the antibody and oligonucleotide probes are used to screen this library to identify clone ⁇ containing cDNA encoding maize endo ⁇ perm amylogenin.
- Clone ⁇ producing ⁇ trong po ⁇ itive ⁇ ignal ⁇ are plaque-purified during additional rounds of screening.
- DNA is prepared from the putative maize endosperm amylogenin cDNA clones. Following restriction endonuclease dige ⁇ tion of the DNA ⁇ with EcoRl and agarose gel electrophoresis, the sizes of the cDNA insert ⁇ of the ⁇ e clones are determined. The cDNA insert is labelled with 32P by nick-translation and used to probe a northern blot of poly(A)-containing RNA from maize endosperm.
- the size of the mRNA bands to which thi ⁇ probe hybridi ⁇ e ⁇ indicate ⁇ the size of the maize endo ⁇ perm amylogenin mRNA. This should be in close agreement with the e ⁇ timate ⁇ from western blots of maize endosperm amylogenin.
- An amplified cDNA library (10 plaque-forming units/ml) from corn endo ⁇ perm constructed on lambda ZAPII was used as the DNA template for PCR.
- a sense primer CC(T/C/A/G)TTCTTCTT(C/T)AA(C/T)AC was designed from the partial amino acid sequence of the protein while the antisense primer, TCGACGGTATCGATAAGC, was from lambda ZAPII nucleotide sequence.
- the PCR product was cloned into a PCR 1000 vector (invitrogen) and sequenced u ⁇ ing Sequenase Version 2.0 (USB). A probe about 500 base pairs in length was obtained containing the deduced sequence for three peptides already sequenced directly. Digoxigenin was then incorporated into the cloned fragment a ⁇ digoxigenin-11-dUPT by mean ⁇ of PCR, u ⁇ ing the modified nucleotide in a 1:2 ratio with dTTP. This served as a probe for screening the cDNA library.
- plaque-forming units of lambda ZAPII phage were used to infect E coil strain XLl-Blue (Stratagene) and after plating the plaques were transferred to nylon membranes in duplicate.
- the hybridisation buffer contained 5xSSC (chloride-citrate), 0.5% blocking reagent (Boehringer), 0.1% N-laurylsarco ⁇ ine, 0.02% SDS and 15 ng/ml of DNA probe. After overnight hybridi ⁇ ation at 65°C, the membrane ⁇ were wa ⁇ hed with O. ⁇ xSSC and 0.1% SDS at 65°C.
- Putative positive clones were detected by the Genius kit (Boehringer), subjected to three additional rounds of purification and excised from lambda ZAPII to yield recombinant pBluescript phagemid carrying ampicillin re ⁇ i ⁇ tance, using ExAssist helper phage in the i ⁇ vivo excision protocol provided by Stratagene, which utilise ⁇ the E coli SOLR ⁇ train.
- the cDNA in ⁇ ert from each clone may be sequenced using standard techniques.
- Each clone will encode a polypeptide equivalent to a partial or a complete amylogenin protein.
- the hydropathy index (Kyte and Doolittle, 1982) and secondary structure predictions (Chou and Fasman, 1978) may be calculated for the encoded protein using the programmes of Devereux et al (1987).
- the Kyte and Doolittle (1982) hydropathy profile indicates the hydrophobic and hydrophilic domain ⁇ within the protein and ⁇ hould be con ⁇ istent with its location in the cell (Kaiser and Bas ⁇ ham, 1979).
- the secondary structure predictions of Chou and Fasman (1978) may be used in compari ⁇ ons of the maize endosperm and animal glycogenin and/or amylogenin proteins.
- amylogenin and/or glycogenin cDNA sequences may be compared to indicate the extent of homology. A detailed comparison of the nucleotide sequences of the cDNA will identify base substitutions, insertions or deletions, and hence the amino acid changes produced in the derived protein sequences.
- amylogenin cDNA clone has been sequenced by the dideoxy method using Sequenase Version 2.0 DNA Sequencing Kit (USB).
- the cDNA clone encoding amylogenin was deposited at the American Type Culture Collection, 12301 Parklawn Drive, Rockville, Maryland 20852, USA under the terms of the Budapest Treaty on 19 August 1993 under the acces ⁇ ion number ATCC 69389.
- Partial cDNA ⁇ equence ⁇ corre ⁇ ponding to amylogenin from B73 maize are given below in Table ⁇ 4 and 5.
- cDNA clones may also be compared by restriction mapping. Restriction maps of the maize endosperm amylogenin cDNAs are constructed to demonstrate their relatedness.
- Sequences may also be compared to other glycogenin and/or amylogenin polypeptide ⁇ .
- amino acid ⁇ equences derived from the maize amylogenin cDNAs may be aligned with the amino acid ⁇ equence ⁇ derived from an animal glycogenin cDNA (Cohen et al, 1990). The homologies between amino acid ⁇ equences are subsequently calculated on the basi ⁇ of thi ⁇ alignment.
- the cDNAs derived as above may be used to probe a maize genomic library to isolate maize amylogenin genomic DNAs.
- the oligonucleotide probe ⁇ generated from the amylogenin N-terminal amino acid ⁇ equence information may be u ⁇ ed to ⁇ creen the maize genomic library.
- the glycogenin and/or amylogenin gene tran ⁇ formation con ⁇ truct requires the presence of an amyloplast tran ⁇ it peptide to en ⁇ ure its correct localisation in the amyloplast. It is believed that chloroplast transit peptides have similar sequences but other potential sources are available such as that attached to ADPG pyrophosphoryla ⁇ e (Plant Mol Biol Reporter, 1991, 9:104-126). Other potential tran ⁇ it peptide ⁇ are tho ⁇ e of ⁇ mall subunit RUBISCO, acetolactate synthase, glyceraldehyde-3P-hydrogenase and nitrite reductase. For example, consen ⁇ us sequence of the transit peptide of small subunit RUBISCO from many genotypes has the sequence:
- the transit peptide of leaf glyceraldehyde-3P- dehydrogenase from corn has the sequence: MAQILAPS TQWQMRITKT SPCATPITSK MWSSLVMKQT KKVAHSAKFR VMAVNSENGT; the putative transit peptide from ADPG pyropho ⁇ phoryla ⁇ e from wheat ha ⁇ the sequence: RASPPSESRA PLRAPQRSAT RQHQARQGPR RMC.
- Pos ⁇ ible promoter ⁇ for use in the invention include the promoters of the starch synthase gene, ADPG pyrophosphorylase gene, and the sucro ⁇ e ⁇ yntha ⁇ e gene. 13. INSERTION OF GLYCOGENIN AND/OR AMYLOGENIN DNA INTO MAIZE
- the glycogenin and/or amylogenin DNA may be transformed into either protoplast ⁇ or other tissue ⁇ of a maize inbred line or population.
- the exi ⁇ ting gene promoter ⁇ in genomic DNA ensure that the extra genes are expre ⁇ ed only in the developing endo ⁇ perm at the correct developmental time.
- the protein ⁇ equences likewise ensure that the enzymes are inserted into the amyloplast.
- Transgenic maize plants are regenerated and the endosperms of these plants are tested for increased glycogenin and/or amylogenin enzyme activity.
- the kernels are also tested for enhanced rate of starch synthe ⁇ i ⁇ at different temperature ⁇ , ⁇ tarch yield, etc.
- the plant ⁇ are then included in a breeding program to produce new maize hybrid ⁇ with altered ⁇ tarch ⁇ ynthe ⁇ i ⁇ .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94908157A EP0658208A1 (en) | 1992-08-26 | 1993-08-26 | Novel plants and processes for obtaining them |
US08/392,816 US5859333A (en) | 1992-08-26 | 1993-08-26 | Plants and processes for obtaining them |
AU49707/93A AU685065B2 (en) | 1992-08-26 | 1993-08-26 | Novel plants and processes for obtaining them |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9218185.8 | 1992-08-26 | ||
GB929218185A GB9218185D0 (en) | 1992-08-26 | 1992-08-26 | Novel plants and processes for obtaining them |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994004693A2 true WO1994004693A2 (en) | 1994-03-03 |
WO1994004693A3 WO1994004693A3 (en) | 1994-03-31 |
Family
ID=10721017
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1993/001821 WO1994004693A2 (en) | 1992-08-26 | 1993-08-26 | Novel plants and processes for obtaining them |
Country Status (6)
Country | Link |
---|---|
US (1) | US5859333A (en) |
EP (1) | EP0658208A1 (en) |
AU (1) | AU685065B2 (en) |
CA (1) | CA2143316A1 (en) |
GB (1) | GB9218185D0 (en) |
WO (1) | WO1994004693A2 (en) |
Cited By (180)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996003513A3 (en) * | 1994-07-28 | 1996-04-25 | Monsanto Co | Isoamylase gene from flaviobacterium sp., compositions containing it and methods using it |
WO1997016554A1 (en) * | 1995-11-03 | 1997-05-09 | John Innes Centre Innovations Limited | Modified plants and plant products |
WO1998050553A1 (en) * | 1997-05-07 | 1998-11-12 | E.I. Du Pont De Nemours And Company | Starch biosynthetic enzymes |
WO1999067404A1 (en) * | 1998-06-23 | 1999-12-29 | Pioneer Hi-Bred International, Inc. | Alteration of hemicellulose concentration in plants by rgp |
US6143562A (en) * | 1995-04-06 | 2000-11-07 | Seminis Vegetable Seeds | Carbon-based process for selection of transgenic plant cells |
US6472588B1 (en) | 1999-09-10 | 2002-10-29 | Texas Tech University | Transgenic cotton plants with altered fiber characteristics transformed with a sucrose phosphate synthase nucleic acid |
WO2004078983A3 (en) * | 2003-03-07 | 2005-01-13 | Basf Plant Science Gmbh | Enhanced amylose production in plants |
WO2006137064A3 (en) * | 2005-06-21 | 2007-02-15 | Univ Ramot | Constructs and methods for generating plants exhibiting altered plasmodesmatal conductance |
EP2039770A2 (en) | 2009-01-06 | 2009-03-25 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants |
EP2039772A2 (en) | 2009-01-06 | 2009-03-25 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants introduction |
EP2039771A2 (en) | 2009-01-06 | 2009-03-25 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants |
EP2072506A1 (en) | 2007-12-21 | 2009-06-24 | Bayer CropScience AG | Thiazolyloxyphenylamidine or thiadiazolyloxyphenylamidine und its use as fungicide |
EP2090168A1 (en) | 2008-02-12 | 2009-08-19 | Bayer CropScience AG | Method for improving plant growth |
EP2168434A1 (en) | 2008-08-02 | 2010-03-31 | Bayer CropScience AG | Use of azols to increase resistance of plants of parts of plants to abiotic stress |
EP2198709A1 (en) | 2008-12-19 | 2010-06-23 | Bayer CropScience AG | Method for treating resistant animal pests |
EP2201838A1 (en) | 2008-12-05 | 2010-06-30 | Bayer CropScience AG | Active ingredient-beneficial organism combinations with insecticide and acaricide properties |
EP2204094A1 (en) | 2008-12-29 | 2010-07-07 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants Introduction |
WO2010083955A2 (en) | 2009-01-23 | 2010-07-29 | Bayer Cropscience Aktiengesellschaft | Use of enaminocarboxylic compounds for fighting viruses transmitted by insects |
WO2010086311A1 (en) | 2009-01-28 | 2010-08-05 | Bayer Cropscience Ag | Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives |
WO2010086095A1 (en) | 2009-01-29 | 2010-08-05 | Bayer Cropscience Ag | Method for improved utilization of the production potential of transgenic plants introduction |
EP2218717A1 (en) | 2009-02-17 | 2010-08-18 | Bayer CropScience AG | Fungicidal N-((HET)Arylethyl)thiocarboxamide derivatives |
WO2010094728A1 (en) | 2009-02-19 | 2010-08-26 | Bayer Cropscience Ag | Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance |
WO2010094666A2 (en) | 2009-02-17 | 2010-08-26 | Bayer Cropscience Ag | Fungicidal n-(phenylcycloalkyl)carboxamide, n-(benzylcycloalkyl)carboxamide and thiocarboxamide derivatives |
EP2223602A1 (en) | 2009-02-23 | 2010-09-01 | Bayer CropScience AG | Method for improved utilisation of the production potential of genetically modified plants |
EP2232995A1 (en) | 2009-03-25 | 2010-09-29 | Bayer CropScience AG | Method for improved utilisation of the production potential of transgenic plants |
EP2239331A1 (en) | 2009-04-07 | 2010-10-13 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants |
EP2251331A1 (en) | 2009-05-15 | 2010-11-17 | Bayer CropScience AG | Fungicide pyrazole carboxamides derivatives |
EP2255626A1 (en) | 2009-05-27 | 2010-12-01 | Bayer CropScience AG | Use of succinate dehydrogenase inhibitors to increase resistance of plants or parts of plants to abiotic stress |
WO2011006603A2 (en) | 2009-07-16 | 2011-01-20 | Bayer Cropscience Ag | Synergistic active substance combinations containing phenyl triazoles |
WO2011015524A2 (en) | 2009-08-03 | 2011-02-10 | Bayer Cropscience Ag | Fungicide heterocycles derivatives |
EP2292094A1 (en) | 2009-09-02 | 2011-03-09 | Bayer CropScience AG | Active compound combinations |
WO2011080256A1 (en) | 2009-12-28 | 2011-07-07 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
WO2011080254A2 (en) | 2009-12-28 | 2011-07-07 | Bayer Cropscience Ag | Fungicide hydroximoyl-heterocycles derivatives |
WO2011080255A2 (en) | 2009-12-28 | 2011-07-07 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
EP2343280A1 (en) | 2009-12-10 | 2011-07-13 | Bayer CropScience AG | Fungicide quinoline derivatives |
WO2011089071A2 (en) | 2010-01-22 | 2011-07-28 | Bayer Cropscience Ag | Acaricide and/or insecticide active substance combinations |
WO2011107504A1 (en) | 2010-03-04 | 2011-09-09 | Bayer Cropscience Ag | Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants |
EP2374791A1 (en) | 2008-08-14 | 2011-10-12 | Bayer CropScience Aktiengesellschaft | Insecticidal 4-phenyl-1H pyrazoles |
WO2011124553A2 (en) | 2010-04-09 | 2011-10-13 | Bayer Cropscience Ag | Use of derivatives of the (1-cyanocyclopropyl)phenylphosphinic acid, the esters thereof and/or the salts thereof for enhancing the tolerance of plants to abiotic stress |
WO2011124554A2 (en) | 2010-04-06 | 2011-10-13 | Bayer Cropscience Ag | Use of 4-phenylbutyric acid and/or the salts thereof for enhancing the stress tolerance of plants |
WO2011134912A1 (en) | 2010-04-28 | 2011-11-03 | Bayer Cropscience Ag | Fungicide hydroximoyl-heterocycles derivatives |
WO2011134913A1 (en) | 2010-04-28 | 2011-11-03 | Bayer Cropscience Ag | Fungicide hydroximoyl-heterocycles derivatives |
WO2011134911A2 (en) | 2010-04-28 | 2011-11-03 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
WO2011151369A1 (en) | 2010-06-03 | 2011-12-08 | Bayer Cropscience Ag | N-[(het)arylethyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues |
WO2011151370A1 (en) | 2010-06-03 | 2011-12-08 | Bayer Cropscience Ag | N-[(het)arylalkyl)] pyrazole (thio)carboxamides and their heterosubstituted analogues |
WO2011151368A2 (en) | 2010-06-03 | 2011-12-08 | Bayer Cropscience Ag | Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives |
WO2011154158A1 (en) | 2010-06-09 | 2011-12-15 | Bayer Bioscience N.V. | Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering |
WO2011154159A1 (en) | 2010-06-09 | 2011-12-15 | Bayer Bioscience N.V. | Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering |
WO2012010579A2 (en) | 2010-07-20 | 2012-01-26 | Bayer Cropscience Ag | Benzocycloalkenes as antifungal agents |
WO2012028578A1 (en) | 2010-09-03 | 2012-03-08 | Bayer Cropscience Ag | Substituted fused pyrimidinones and dihydropyrimidinones |
WO2012038480A2 (en) | 2010-09-22 | 2012-03-29 | Bayer Cropscience Ag | Use of biological or chemical control agents for controlling insects and nematodes in resistant crops |
WO2012045798A1 (en) | 2010-10-07 | 2012-04-12 | Bayer Cropscience Ag | Fungicide composition comprising a tetrazolyloxime derivative and a thiazolylpiperidine derivative |
WO2012052490A1 (en) | 2010-10-21 | 2012-04-26 | Bayer Cropscience Ag | N-benzyl heterocyclic carboxamides |
WO2012052489A1 (en) | 2010-10-21 | 2012-04-26 | Bayer Cropscience Ag | 1-(heterocyclic carbonyl) piperidines |
WO2012059497A1 (en) | 2010-11-02 | 2012-05-10 | Bayer Cropscience Ag | N-hetarylmethyl pyrazolylcarboxamides |
WO2012065944A1 (en) | 2010-11-15 | 2012-05-24 | Bayer Cropscience Ag | N-aryl pyrazole(thio)carboxamides |
WO2012065947A1 (en) | 2010-11-15 | 2012-05-24 | Bayer Cropscience Ag | 5-halogenopyrazolecarboxamides |
WO2012065945A1 (en) | 2010-11-15 | 2012-05-24 | Bayer Cropscience Ag | 5-halogenopyrazole(thio)carboxamides |
EP2460407A1 (en) | 2010-12-01 | 2012-06-06 | Bayer CropScience AG | Agent combinations comprising pyridylethyl benzamides and other agents |
EP2460406A1 (en) | 2010-12-01 | 2012-06-06 | Bayer CropScience AG | Use of fluopyram for controlling nematodes in nematode resistant crops |
WO2012072660A1 (en) | 2010-12-01 | 2012-06-07 | Bayer Cropscience Ag | Use of fluopyram for controlling nematodes in crops and for increasing yield |
WO2012089722A2 (en) | 2010-12-30 | 2012-07-05 | Bayer Cropscience Ag | Use of open-chain carboxylic acids, carbonic esters, carboxamides and carbonitriles of aryl, heteroaryl and benzylsulfonamide or the salts thereof for improving the stress tolerance in plants |
WO2012089757A1 (en) | 2010-12-29 | 2012-07-05 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
EP2474542A1 (en) | 2010-12-29 | 2012-07-11 | Bayer CropScience AG | Fungicide hydroximoyl-tetrazole derivatives |
EP2494867A1 (en) | 2011-03-01 | 2012-09-05 | Bayer CropScience AG | Halogen-substituted compounds in combination with fungicides |
WO2012120105A1 (en) | 2011-03-10 | 2012-09-13 | Bayer Cropscience Ag | Use of lipochito-oligosaccharide compounds for safeguarding seed safety of treated seeds |
WO2012123434A1 (en) | 2011-03-14 | 2012-09-20 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
WO2012136581A1 (en) | 2011-04-08 | 2012-10-11 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
EP2511255A1 (en) | 2011-04-15 | 2012-10-17 | Bayer CropScience AG | Substituted prop-2-in-1-ol and prop-2-en-1-ol derivatives |
WO2012139890A1 (en) | 2011-04-15 | 2012-10-18 | Bayer Cropscience Ag | Substituted 5-(cyclohex-2-en-1-yl)-penta-2,4-dienes and 5-(cyclohex-2-en-1-yl)-pent-2-en-4-ines as active agents against abiotic stress in plants |
WO2012139892A1 (en) | 2011-04-15 | 2012-10-18 | Bayer Cropscience Ag | Substituted 5-(bicyclo[4.1.0]hept-3-en-2-yl)-penta-2,4-dienes and 5-(bicyclo[4.1.0]hept-3-en-2-yl)-pent-2-ene-4-ines as active agents against abiotic stress in plants |
WO2012139891A1 (en) | 2011-04-15 | 2012-10-18 | Bayer Cropscience Ag | Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants |
US8299302B2 (en) | 2007-03-12 | 2012-10-30 | Bayer Cropscience Ag | 4-Cycloalkyl or 4-substituted phenoxyphenylamidines and use thereof as fungicides |
WO2012168124A1 (en) | 2011-06-06 | 2012-12-13 | Bayer Cropscience Nv | Methods and means to modify a plant genome at a preselected site |
US8334237B2 (en) | 2007-03-12 | 2012-12-18 | Bayer Cropscience Ag | Substituted phenylamidines and the use thereof as fungicides |
WO2013004652A1 (en) | 2011-07-04 | 2013-01-10 | Bayer Intellectual Property Gmbh | Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants |
WO2013020985A1 (en) | 2011-08-10 | 2013-02-14 | Bayer Intellectual Property Gmbh | Active compound combinations comprising specific tetramic acid derivatives |
EP2561759A1 (en) | 2011-08-26 | 2013-02-27 | Bayer Cropscience AG | Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth |
WO2013026740A2 (en) | 2011-08-22 | 2013-02-28 | Bayer Cropscience Nv | Methods and means to modify a plant genome |
WO2013026836A1 (en) | 2011-08-22 | 2013-02-28 | Bayer Intellectual Property Gmbh | Fungicide hydroximoyl-tetrazole derivatives |
US8394991B2 (en) | 2007-03-12 | 2013-03-12 | Bayer Cropscience Ag | Phenoxy substituted phenylamidine derivatives and their use as fungicides |
WO2013034621A1 (en) | 2011-09-09 | 2013-03-14 | Bayer Intellectual Property Gmbh | Acyl-homoserine lactone derivatives for improving plant yield |
WO2013037717A1 (en) | 2011-09-12 | 2013-03-21 | Bayer Intellectual Property Gmbh | Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4h)-one derivatives |
WO2013037958A1 (en) | 2011-09-16 | 2013-03-21 | Bayer Intellectual Property Gmbh | Use of phenylpyrazolin-3-carboxylates for improving plant yield |
WO2013037955A1 (en) | 2011-09-16 | 2013-03-21 | Bayer Intellectual Property Gmbh | Use of acylsulfonamides for improving plant yield |
WO2013037956A1 (en) | 2011-09-16 | 2013-03-21 | Bayer Intellectual Property Gmbh | Use of 5-phenyl- or 5-benzyl-2 isoxazoline-3 carboxylates for improving plant yield |
WO2013041602A1 (en) | 2011-09-23 | 2013-03-28 | Bayer Intellectual Property Gmbh | Use of 4-substituted 1-phenyl-pyrazole-3-carboxylic-acid derivatives as agents against abiotic plant stress |
WO2013050324A1 (en) | 2011-10-06 | 2013-04-11 | Bayer Intellectual Property Gmbh | Combination, containing 4-phenylbutyric acid (4-pba) or a salt thereof (component (a)) and one or more selected additional agronomically active compounds (component(s) (b)), that reduces abiotic plant stress |
WO2013050410A1 (en) | 2011-10-04 | 2013-04-11 | Bayer Intellectual Property Gmbh | RNAi FOR THE CONTROL OF FUNGI AND OOMYCETES BY INHIBITING SACCHAROPINE DEHYDROGENASE GENE |
WO2013075817A1 (en) | 2011-11-21 | 2013-05-30 | Bayer Intellectual Property Gmbh | Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives |
US8455480B2 (en) | 2007-09-26 | 2013-06-04 | Bayer Cropscience Ag | Active agent combinations having insecticidal and acaricidal properties |
WO2013079566A2 (en) | 2011-11-30 | 2013-06-06 | Bayer Intellectual Property Gmbh | Fungicidal n-bicycloalkyl and n-tricycloalkyl (thio)carboxamide derivatives |
WO2013092519A1 (en) | 2011-12-19 | 2013-06-27 | Bayer Cropscience Ag | Use of anthranilic acid diamide derivatives for pest control in transgenic crops |
WO2013098147A1 (en) | 2011-12-29 | 2013-07-04 | Bayer Intellectual Property Gmbh | Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives |
WO2013098146A1 (en) | 2011-12-29 | 2013-07-04 | Bayer Intellectual Property Gmbh | Fungicidal 3-[(1,3-thiazol-4-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives |
US8487118B2 (en) | 2009-01-19 | 2013-07-16 | Bayer Cropscience Ag | Cyclic diones and their use as insecticides, acaricides and/or fungicides |
US8519003B2 (en) | 2007-03-12 | 2013-08-27 | Bayer Cropscience Ag | Phenoxyphenylamidines as fungicides |
WO2013124275A1 (en) | 2012-02-22 | 2013-08-29 | Bayer Cropscience Ag | Use of succinate dehydrogenase inhibitors (sdhis) for controlling wood diseases in grape. |
WO2013127704A1 (en) | 2012-02-27 | 2013-09-06 | Bayer Intellectual Property Gmbh | Active compound combinations containing a thiazoylisoxazoline and a fungicide |
WO2013139949A1 (en) | 2012-03-23 | 2013-09-26 | Bayer Intellectual Property Gmbh | Compositions comprising a strigolactame compound for enhanced plant growth and yield |
WO2013153143A1 (en) | 2012-04-12 | 2013-10-17 | Bayer Cropscience Ag | N-acyl- 2 - (cyclo) alkylpyrrolidines and piperidines useful as fungicides |
WO2013156559A1 (en) | 2012-04-20 | 2013-10-24 | Bayer Cropscience Ag | N-cycloalkyl-n-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives |
WO2013156560A1 (en) | 2012-04-20 | 2013-10-24 | Bayer Cropscience Ag | N-cycloalkyl-n-[(trisubstitutedsilylphenyl)methylene]-(thio)carboxamide derivatives |
WO2013160230A1 (en) | 2012-04-23 | 2013-10-31 | Bayer Cropscience Nv | Targeted genome engineering in plants |
EP2662361A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | Pyrazol indanyl carboxamides |
EP2662363A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | 5-Halogenopyrazole biphenylcarboxamides |
EP2662360A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | 5-Halogenopyrazole indanyl carboxamides |
EP2662370A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | 5-Halogenopyrazole benzofuranyl carboxamides |
EP2662364A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | Pyrazole tetrahydronaphthyl carboxamides |
EP2662362A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | Pyrazole indanyl carboxamides |
WO2013167544A1 (en) | 2012-05-09 | 2013-11-14 | Bayer Cropscience Ag | 5-halogenopyrazole indanyl carboxamides |
WO2013167545A1 (en) | 2012-05-09 | 2013-11-14 | Bayer Cropscience Ag | Pyrazole indanyl carboxamides |
WO2013174836A1 (en) | 2012-05-22 | 2013-11-28 | Bayer Cropscience Ag | Active compounds combinations comprising a lipo-chitooligosaccharide derivative and a nematicide, insecticidal or fungicidal compound |
WO2014009322A1 (en) | 2012-07-11 | 2014-01-16 | Bayer Cropscience Ag | Use of fungicidal combinations for increasing the tolerance of a plant towards abiotic stress |
WO2014037340A1 (en) | 2012-09-05 | 2014-03-13 | Bayer Cropscience Ag | Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress |
WO2014060520A1 (en) | 2012-10-19 | 2014-04-24 | Bayer Cropscience Ag | Method for treating plants against fungi resistant to fungicides using carboxamide or thiocarboxamide derivatives |
WO2014060502A1 (en) | 2012-10-19 | 2014-04-24 | Bayer Cropscience Ag | Active compound combinations comprising carboxamide derivatives |
WO2014060519A1 (en) | 2012-10-19 | 2014-04-24 | Bayer Cropscience Ag | Method for enhancing tolerance to abiotic stress in plants using carboxamide or thiocarboxamide derivatives |
WO2014060518A1 (en) | 2012-10-19 | 2014-04-24 | Bayer Cropscience Ag | Method of plant growth promotion using carboxamide derivatives |
EP2735231A1 (en) | 2012-11-23 | 2014-05-28 | Bayer CropScience AG | Active compound combinations |
WO2014079957A1 (en) | 2012-11-23 | 2014-05-30 | Bayer Cropscience Ag | Selective inhibition of ethylene signal transduction |
WO2014083089A1 (en) | 2012-11-30 | 2014-06-05 | Bayer Cropscience Ag | Ternary fungicidal and pesticidal mixtures |
WO2014083033A1 (en) | 2012-11-30 | 2014-06-05 | Bayer Cropsience Ag | Binary fungicidal or pesticidal mixture |
WO2014083088A2 (en) | 2012-11-30 | 2014-06-05 | Bayer Cropscience Ag | Binary fungicidal mixtures |
WO2014083031A2 (en) | 2012-11-30 | 2014-06-05 | Bayer Cropscience Ag | Binary pesticidal and fungicidal mixtures |
WO2014082950A1 (en) | 2012-11-30 | 2014-06-05 | Bayer Cropscience Ag | Ternary fungicidal mixtures |
EP2740720A1 (en) | 2012-12-05 | 2014-06-11 | Bayer CropScience AG | Substituted bicyclic and tricyclic pent-2-en-4-inic acid derivatives and their use for enhancing the stress tolerance in plants |
EP2740356A1 (en) | 2012-12-05 | 2014-06-11 | Bayer CropScience AG | Substituted (2Z)-5(1-Hydroxycyclohexyl)pent-2-en-4-inic acid derivatives |
WO2014086751A1 (en) | 2012-12-05 | 2014-06-12 | Bayer Cropscience Ag | Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cyloalkenyl ethynyl)-cyclohexanols as active agents against abiotic plant stress |
WO2014090765A1 (en) | 2012-12-12 | 2014-06-19 | Bayer Cropscience Ag | Use of 1-[2-fluoro-4-methyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl]-5-amino-3-trifluoromethyl)-1 h-1,2,4 tfia zole for controlling nematodes in nematode-resistant crops |
WO2014095826A1 (en) | 2012-12-18 | 2014-06-26 | Bayer Cropscience Ag | Binary fungicidal and bactericidal combinations |
WO2014095677A1 (en) | 2012-12-19 | 2014-06-26 | Bayer Cropscience Ag | Difluoromethyl-nicotinic- tetrahydronaphtyl carboxamides |
US8796175B2 (en) | 2008-08-29 | 2014-08-05 | Bayer Cropscience Ag | Method for enhancing plant intrinsic defense |
US8828906B2 (en) | 2009-03-25 | 2014-09-09 | Bayer Cropscience Ag | Active compound combinations having insecticidal and acaricidal properties |
US8828907B2 (en) | 2009-03-25 | 2014-09-09 | Bayer Cropscience Ag | Active ingredient combinations having insecticidal and acaricidal properties |
WO2014135608A1 (en) | 2013-03-07 | 2014-09-12 | Bayer Cropscience Ag | Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-heterocycle derivatives |
US8835657B2 (en) | 2009-05-06 | 2014-09-16 | Bayer Cropscience Ag | Cyclopentanedione compounds and their use as insecticides, acaricides and/or fungicides |
US8846567B2 (en) | 2009-03-25 | 2014-09-30 | Bayer Cropscience Ag | Active compound combinations having insecticidal and acaricidal properties |
US8846568B2 (en) | 2009-03-25 | 2014-09-30 | Bayer Cropscience Ag | Active compound combinations having insecticidal and acaricidal properties |
WO2014161821A1 (en) | 2013-04-02 | 2014-10-09 | Bayer Cropscience Nv | Targeted genome engineering in eukaryotes |
WO2014167009A1 (en) | 2013-04-12 | 2014-10-16 | Bayer Cropscience Ag | Novel triazole derivatives |
WO2014167008A1 (en) | 2013-04-12 | 2014-10-16 | Bayer Cropscience Ag | Novel triazolinthione derivatives |
WO2014170345A2 (en) | 2013-04-19 | 2014-10-23 | Bayer Cropscience Ag | Method for improved utilization of the production potential of transgenic plants |
WO2014170364A1 (en) | 2013-04-19 | 2014-10-23 | Bayer Cropscience Ag | Binary insecticidal or pesticidal mixture |
WO2014177514A1 (en) | 2013-04-30 | 2014-11-06 | Bayer Cropscience Ag | Nematicidal n-substituted phenethylcarboxamides |
WO2014177582A1 (en) | 2013-04-30 | 2014-11-06 | Bayer Cropscience Ag | N-(2-fluoro-2-phenethyl)carboxamides as nematicides and endoparasiticides |
WO2014206953A1 (en) | 2013-06-26 | 2014-12-31 | Bayer Cropscience Ag | N-cycloalkyl-n-[(bicyclylphenyl)methylene]-(thio)carboxamide derivatives |
US8927583B2 (en) | 2006-12-22 | 2015-01-06 | Bayer Cropscience Ag | Pesticidal composition comprising a 2-pyrdilmethylbenzamide derivative and an insecticide compound |
WO2015004040A1 (en) | 2013-07-09 | 2015-01-15 | Bayer Cropscience Ag | Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress |
US9012360B2 (en) | 2009-03-25 | 2015-04-21 | Bayer Intellectual Property Gmbh | Synergistic combinations of active ingredients |
WO2015082586A1 (en) | 2013-12-05 | 2015-06-11 | Bayer Cropscience Ag | N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives |
WO2015082587A1 (en) | 2013-12-05 | 2015-06-11 | Bayer Cropscience Ag | N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives |
US9199922B2 (en) | 2007-03-12 | 2015-12-01 | Bayer Intellectual Property Gmbh | Dihalophenoxyphenylamidines and use thereof as fungicides |
US9232794B2 (en) | 2009-06-02 | 2016-01-12 | Bayer Intellectual Property Gmbh | Use of succinate dehydrogenase inhibitors for controlling Sclerotinia ssp |
WO2016012362A1 (en) | 2014-07-22 | 2016-01-28 | Bayer Cropscience Aktiengesellschaft | Substituted cyano cycloalkyl penta-2,4-dienes, cyano cycloalkyl pent-2-en-4-ynes, cyano heterocyclyl penta-2,4-dienes and cyano heterocyclyl pent-2-en-4-ynes as active substances against abiotic plant stress |
EP2997825A1 (en) | 2011-04-22 | 2016-03-23 | Bayer Intellectual Property GmbH | Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound |
EP3000809A1 (en) | 2009-05-15 | 2016-03-30 | Bayer Intellectual Property GmbH | Fungicide pyrazole carboxamides derivatives |
WO2016096942A1 (en) | 2014-12-18 | 2016-06-23 | Bayer Cropscience Aktiengesellschaft | Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress |
WO2016166077A1 (en) | 2015-04-13 | 2016-10-20 | Bayer Cropscience Aktiengesellschaft | N-cycloalkyl-n-(biheterocyclyethylene)-(thio)carboxamide derivatives |
US9763451B2 (en) | 2008-12-29 | 2017-09-19 | Bayer Intellectual Property Gmbh | Method for improved use of the production potential of genetically modified plants |
WO2018019676A1 (en) | 2016-07-29 | 2018-02-01 | Bayer Cropscience Aktiengesellschaft | Active compound combinations and methods to protect the propagation material of plants |
WO2018054911A1 (en) | 2016-09-23 | 2018-03-29 | Bayer Cropscience Nv | Targeted genome optimization in plants |
WO2018054829A1 (en) | 2016-09-22 | 2018-03-29 | Bayer Cropscience Aktiengesellschaft | Novel triazole derivatives and their use as fungicides |
WO2018054832A1 (en) | 2016-09-22 | 2018-03-29 | Bayer Cropscience Aktiengesellschaft | Novel triazole derivatives |
WO2018077711A2 (en) | 2016-10-26 | 2018-05-03 | Bayer Cropscience Aktiengesellschaft | Use of pyraziflumid for controlling sclerotinia spp in seed treatment applications |
EP3332645A1 (en) | 2016-12-12 | 2018-06-13 | Bayer Cropscience AG | Use of substituted pyrimidine diones or their salts as agents to combat abiotic plant stress |
WO2018104392A1 (en) | 2016-12-08 | 2018-06-14 | Bayer Cropscience Aktiengesellschaft | Use of insecticides for controlling wireworms |
WO2018108627A1 (en) | 2016-12-12 | 2018-06-21 | Bayer Cropscience Aktiengesellschaft | Use of substituted indolinylmethyl sulfonamides, or the salts thereof for increasing the stress tolerance of plants |
DE102007045919B4 (en) | 2007-09-26 | 2018-07-05 | Bayer Intellectual Property Gmbh | Drug combinations with insecticidal and acaricidal properties |
DE102007045920B4 (en) | 2007-09-26 | 2018-07-05 | Bayer Intellectual Property Gmbh | Synergistic drug combinations |
DE102007045953B4 (en) | 2007-09-26 | 2018-07-05 | Bayer Intellectual Property Gmbh | Drug combinations with insecticidal and acaricidal properties |
WO2019025153A1 (en) | 2017-07-31 | 2019-02-07 | Bayer Cropscience Aktiengesellschaft | Use of substituted n-sulfonyl-n'-aryl diaminoalkanes and n-sulfonyl-n'-heteroaryl diaminoalkanes or salts thereof for increasing the stress tolerance in plants |
WO2019060746A1 (en) | 2017-09-21 | 2019-03-28 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
WO2019126709A1 (en) | 2017-12-22 | 2019-06-27 | The Broad Institute, Inc. | Cas12b systems, methods, and compositions for targeted dna base editing |
WO2019233863A1 (en) | 2018-06-04 | 2019-12-12 | Bayer Aktiengesellschaft | Herbicidally active bicyclic benzoylpyrazoles |
WO2020131862A1 (en) | 2018-12-17 | 2020-06-25 | The Broad Institute, Inc. | Crispr-associated transposase systems and methods of use thereof |
US10968257B2 (en) | 2018-04-03 | 2021-04-06 | The Broad Institute, Inc. | Target recognition motifs and uses thereof |
US11180751B2 (en) | 2015-06-18 | 2021-11-23 | The Broad Institute, Inc. | CRISPR enzymes and systems |
US11591601B2 (en) | 2017-05-05 | 2023-02-28 | The Broad Institute, Inc. | Methods for identification and modification of lncRNA associated with target genotypes and phenotypes |
US12297436B2 (en) | 2017-05-18 | 2025-05-13 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6420629B1 (en) | 1996-09-09 | 2002-07-16 | B.C. Research Inc. | Process of increasing plant growth and yield and modifying cellulose production in plants |
US7759547B2 (en) | 1999-09-22 | 2010-07-20 | National Research Council Of Canada | Methods of producing and growing plants having improved phosphorus utilization |
GB0119342D0 (en) * | 2001-08-08 | 2001-10-03 | Gemstar Cambridge Ltd | Starch modification |
CL2007003743A1 (en) * | 2006-12-22 | 2008-07-11 | Bayer Cropscience Ag | COMPOSITION THAT INCLUDES FENAMIDONA AND AN INSECTICIDE COMPOUND; AND METHOD TO CONTROL FITOPATOGENOS CULTURES AND INSECTS FACING OR PREVENTIVELY. |
EP1969931A1 (en) * | 2007-03-12 | 2008-09-17 | Bayer CropScience Aktiengesellschaft | Fluoroalkyl phenylamidines and their use as fungicides |
US8080688B2 (en) * | 2007-03-12 | 2011-12-20 | Bayer Cropscience Ag | 3, 4-disubstituted phenoxyphenylamidines and use thereof as fungicides |
BRPI0810654B1 (en) * | 2007-04-19 | 2016-10-04 | Bayer Cropscience Ag | thiadiazolyloxyphenylamidines, their use and their method of preparation, composition and method for combating unwanted microorganisms, seed resistant to unwanted microorganism, as well as method for protecting said seed against microorganisms |
DE102007045922A1 (en) | 2007-09-26 | 2009-04-02 | Bayer Cropscience Ag | Drug combinations with insecticidal and acaricidal properties |
CN103368705B (en) | 2008-02-08 | 2017-07-14 | 奥普蒂斯蜂窝技术有限责任公司 | Method and apparatus in telecommunication system |
US9557335B2 (en) * | 2011-08-01 | 2017-01-31 | Biologistics Llc | Method of isolating and identifying fruit oligosaccharides from ripe banana fruit |
WO2020053933A1 (en) * | 2018-09-10 | 2020-03-19 | オリンパス株式会社 | Thermal insult observation device and thermal insult observation method |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5095174A (en) * | 1989-08-30 | 1992-03-10 | Pioneer Hi-Bred International, Inc. | Inbred corn line PHK35 |
US5349123A (en) * | 1990-12-21 | 1994-09-20 | Calgene, Inc. | Glycogen biosynthetic enzymes in plants |
-
1992
- 1992-08-26 GB GB929218185A patent/GB9218185D0/en active Pending
-
1993
- 1993-08-26 US US08/392,816 patent/US5859333A/en not_active Expired - Fee Related
- 1993-08-26 EP EP94908157A patent/EP0658208A1/en not_active Withdrawn
- 1993-08-26 AU AU49707/93A patent/AU685065B2/en not_active Ceased
- 1993-08-26 WO PCT/GB1993/001821 patent/WO1994004693A2/en not_active Application Discontinuation
- 1993-08-26 CA CA002143316A patent/CA2143316A1/en not_active Abandoned
Cited By (207)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996003513A3 (en) * | 1994-07-28 | 1996-04-25 | Monsanto Co | Isoamylase gene from flaviobacterium sp., compositions containing it and methods using it |
US6143562A (en) * | 1995-04-06 | 2000-11-07 | Seminis Vegetable Seeds | Carbon-based process for selection of transgenic plant cells |
WO1997016554A1 (en) * | 1995-11-03 | 1997-05-09 | John Innes Centre Innovations Limited | Modified plants and plant products |
WO1998050553A1 (en) * | 1997-05-07 | 1998-11-12 | E.I. Du Pont De Nemours And Company | Starch biosynthetic enzymes |
US6255114B1 (en) | 1997-05-07 | 2001-07-03 | E. I. Du Pont De Nemours & Company | Starch biosynthetic enzymes |
WO1999067404A1 (en) * | 1998-06-23 | 1999-12-29 | Pioneer Hi-Bred International, Inc. | Alteration of hemicellulose concentration in plants by rgp |
US6194638B1 (en) * | 1998-06-23 | 2001-02-27 | Pioneer Hi-Bred International, Inc. | Alteration of hemicellulose concentration in plants |
US6472588B1 (en) | 1999-09-10 | 2002-10-29 | Texas Tech University | Transgenic cotton plants with altered fiber characteristics transformed with a sucrose phosphate synthase nucleic acid |
US7091400B2 (en) | 1999-09-10 | 2006-08-15 | Texas Tech University | Transgenic fiber producing plants with increased expression of sucrose phosphate synthase |
WO2004078983A3 (en) * | 2003-03-07 | 2005-01-13 | Basf Plant Science Gmbh | Enhanced amylose production in plants |
WO2006137064A3 (en) * | 2005-06-21 | 2007-02-15 | Univ Ramot | Constructs and methods for generating plants exhibiting altered plasmodesmatal conductance |
US8927583B2 (en) | 2006-12-22 | 2015-01-06 | Bayer Cropscience Ag | Pesticidal composition comprising a 2-pyrdilmethylbenzamide derivative and an insecticide compound |
US8785692B2 (en) | 2007-03-12 | 2014-07-22 | Bayer Cropscience Ag | Substituted phenylamidines and the use thereof as fungicides |
US8748662B2 (en) | 2007-03-12 | 2014-06-10 | Bayer Cropscience Ag | 4-cycloalkyl or 4-aryl substituted phenoxyphenylamidines and use thereof as fungicides |
US9199922B2 (en) | 2007-03-12 | 2015-12-01 | Bayer Intellectual Property Gmbh | Dihalophenoxyphenylamidines and use thereof as fungicides |
US8299302B2 (en) | 2007-03-12 | 2012-10-30 | Bayer Cropscience Ag | 4-Cycloalkyl or 4-substituted phenoxyphenylamidines and use thereof as fungicides |
US8334237B2 (en) | 2007-03-12 | 2012-12-18 | Bayer Cropscience Ag | Substituted phenylamidines and the use thereof as fungicides |
US8394991B2 (en) | 2007-03-12 | 2013-03-12 | Bayer Cropscience Ag | Phenoxy substituted phenylamidine derivatives and their use as fungicides |
US8519003B2 (en) | 2007-03-12 | 2013-08-27 | Bayer Cropscience Ag | Phenoxyphenylamidines as fungicides |
US8455480B2 (en) | 2007-09-26 | 2013-06-04 | Bayer Cropscience Ag | Active agent combinations having insecticidal and acaricidal properties |
DE102007045919B4 (en) | 2007-09-26 | 2018-07-05 | Bayer Intellectual Property Gmbh | Drug combinations with insecticidal and acaricidal properties |
DE102007045920B4 (en) | 2007-09-26 | 2018-07-05 | Bayer Intellectual Property Gmbh | Synergistic drug combinations |
DE102007045953B4 (en) | 2007-09-26 | 2018-07-05 | Bayer Intellectual Property Gmbh | Drug combinations with insecticidal and acaricidal properties |
EP2072506A1 (en) | 2007-12-21 | 2009-06-24 | Bayer CropScience AG | Thiazolyloxyphenylamidine or thiadiazolyloxyphenylamidine und its use as fungicide |
EP2090168A1 (en) | 2008-02-12 | 2009-08-19 | Bayer CropScience AG | Method for improving plant growth |
EP2168434A1 (en) | 2008-08-02 | 2010-03-31 | Bayer CropScience AG | Use of azols to increase resistance of plants of parts of plants to abiotic stress |
EP2374791A1 (en) | 2008-08-14 | 2011-10-12 | Bayer CropScience Aktiengesellschaft | Insecticidal 4-phenyl-1H pyrazoles |
US8796175B2 (en) | 2008-08-29 | 2014-08-05 | Bayer Cropscience Ag | Method for enhancing plant intrinsic defense |
EP2201838A1 (en) | 2008-12-05 | 2010-06-30 | Bayer CropScience AG | Active ingredient-beneficial organism combinations with insecticide and acaricide properties |
EP2198709A1 (en) | 2008-12-19 | 2010-06-23 | Bayer CropScience AG | Method for treating resistant animal pests |
WO2010075994A1 (en) | 2008-12-29 | 2010-07-08 | Bayer Cropscience Aktiengesellschaft | Treatment of transgenic crops with mixtures of fiproles and chloronicotinyls |
EP2204094A1 (en) | 2008-12-29 | 2010-07-07 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants Introduction |
US9763451B2 (en) | 2008-12-29 | 2017-09-19 | Bayer Intellectual Property Gmbh | Method for improved use of the production potential of genetically modified plants |
EP2039772A2 (en) | 2009-01-06 | 2009-03-25 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants introduction |
EP2039771A2 (en) | 2009-01-06 | 2009-03-25 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants |
EP2039770A2 (en) | 2009-01-06 | 2009-03-25 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants |
US8487118B2 (en) | 2009-01-19 | 2013-07-16 | Bayer Cropscience Ag | Cyclic diones and their use as insecticides, acaricides and/or fungicides |
WO2010083955A2 (en) | 2009-01-23 | 2010-07-29 | Bayer Cropscience Aktiengesellschaft | Use of enaminocarboxylic compounds for fighting viruses transmitted by insects |
EP2227951A1 (en) | 2009-01-23 | 2010-09-15 | Bayer CropScience AG | Application of enaminocarbonyl compounds for combating viruses transmitted by insects |
WO2010086311A1 (en) | 2009-01-28 | 2010-08-05 | Bayer Cropscience Ag | Fungicide n-cycloalkyl-n-bicyclicmethylene-carboxamide derivatives |
WO2010086095A1 (en) | 2009-01-29 | 2010-08-05 | Bayer Cropscience Ag | Method for improved utilization of the production potential of transgenic plants introduction |
EP2218717A1 (en) | 2009-02-17 | 2010-08-18 | Bayer CropScience AG | Fungicidal N-((HET)Arylethyl)thiocarboxamide derivatives |
WO2010094666A2 (en) | 2009-02-17 | 2010-08-26 | Bayer Cropscience Ag | Fungicidal n-(phenylcycloalkyl)carboxamide, n-(benzylcycloalkyl)carboxamide and thiocarboxamide derivatives |
WO2010094728A1 (en) | 2009-02-19 | 2010-08-26 | Bayer Cropscience Ag | Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance |
EP2223602A1 (en) | 2009-02-23 | 2010-09-01 | Bayer CropScience AG | Method for improved utilisation of the production potential of genetically modified plants |
US8828907B2 (en) | 2009-03-25 | 2014-09-09 | Bayer Cropscience Ag | Active ingredient combinations having insecticidal and acaricidal properties |
US8828906B2 (en) | 2009-03-25 | 2014-09-09 | Bayer Cropscience Ag | Active compound combinations having insecticidal and acaricidal properties |
EP2232995A1 (en) | 2009-03-25 | 2010-09-29 | Bayer CropScience AG | Method for improved utilisation of the production potential of transgenic plants |
US9012360B2 (en) | 2009-03-25 | 2015-04-21 | Bayer Intellectual Property Gmbh | Synergistic combinations of active ingredients |
US8846568B2 (en) | 2009-03-25 | 2014-09-30 | Bayer Cropscience Ag | Active compound combinations having insecticidal and acaricidal properties |
US8846567B2 (en) | 2009-03-25 | 2014-09-30 | Bayer Cropscience Ag | Active compound combinations having insecticidal and acaricidal properties |
EP2239331A1 (en) | 2009-04-07 | 2010-10-13 | Bayer CropScience AG | Method for improved utilization of the production potential of transgenic plants |
US8835657B2 (en) | 2009-05-06 | 2014-09-16 | Bayer Cropscience Ag | Cyclopentanedione compounds and their use as insecticides, acaricides and/or fungicides |
EP3000809A1 (en) | 2009-05-15 | 2016-03-30 | Bayer Intellectual Property GmbH | Fungicide pyrazole carboxamides derivatives |
EP2251331A1 (en) | 2009-05-15 | 2010-11-17 | Bayer CropScience AG | Fungicide pyrazole carboxamides derivatives |
EP2255626A1 (en) | 2009-05-27 | 2010-12-01 | Bayer CropScience AG | Use of succinate dehydrogenase inhibitors to increase resistance of plants or parts of plants to abiotic stress |
US9877482B2 (en) | 2009-06-02 | 2018-01-30 | Bayer Intellectual Property Gmbh | Use of succinate dehydrogenase inhibitors for controlling Sclerotinia ssp |
US9232794B2 (en) | 2009-06-02 | 2016-01-12 | Bayer Intellectual Property Gmbh | Use of succinate dehydrogenase inhibitors for controlling Sclerotinia ssp |
WO2011006603A2 (en) | 2009-07-16 | 2011-01-20 | Bayer Cropscience Ag | Synergistic active substance combinations containing phenyl triazoles |
WO2011015524A2 (en) | 2009-08-03 | 2011-02-10 | Bayer Cropscience Ag | Fungicide heterocycles derivatives |
EP2292094A1 (en) | 2009-09-02 | 2011-03-09 | Bayer CropScience AG | Active compound combinations |
WO2011035834A1 (en) | 2009-09-02 | 2011-03-31 | Bayer Cropscience Ag | Active compound combinations |
EP2343280A1 (en) | 2009-12-10 | 2011-07-13 | Bayer CropScience AG | Fungicide quinoline derivatives |
WO2011080256A1 (en) | 2009-12-28 | 2011-07-07 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
WO2011080254A2 (en) | 2009-12-28 | 2011-07-07 | Bayer Cropscience Ag | Fungicide hydroximoyl-heterocycles derivatives |
WO2011080255A2 (en) | 2009-12-28 | 2011-07-07 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
US8722072B2 (en) | 2010-01-22 | 2014-05-13 | Bayer Intellectual Property Gmbh | Acaricidal and/or insecticidal active ingredient combinations |
WO2011089071A2 (en) | 2010-01-22 | 2011-07-28 | Bayer Cropscience Ag | Acaricide and/or insecticide active substance combinations |
WO2011107504A1 (en) | 2010-03-04 | 2011-09-09 | Bayer Cropscience Ag | Fluoroalkyl-substituted 2-amidobenzimidazoles and the use thereof for boosting stress tolerance in plants |
WO2011124554A2 (en) | 2010-04-06 | 2011-10-13 | Bayer Cropscience Ag | Use of 4-phenylbutyric acid and/or the salts thereof for enhancing the stress tolerance of plants |
WO2011124553A2 (en) | 2010-04-09 | 2011-10-13 | Bayer Cropscience Ag | Use of derivatives of the (1-cyanocyclopropyl)phenylphosphinic acid, the esters thereof and/or the salts thereof for enhancing the tolerance of plants to abiotic stress |
WO2011134913A1 (en) | 2010-04-28 | 2011-11-03 | Bayer Cropscience Ag | Fungicide hydroximoyl-heterocycles derivatives |
WO2011134911A2 (en) | 2010-04-28 | 2011-11-03 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
WO2011134912A1 (en) | 2010-04-28 | 2011-11-03 | Bayer Cropscience Ag | Fungicide hydroximoyl-heterocycles derivatives |
WO2011151370A1 (en) | 2010-06-03 | 2011-12-08 | Bayer Cropscience Ag | N-[(het)arylalkyl)] pyrazole (thio)carboxamides and their heterosubstituted analogues |
WO2011151369A1 (en) | 2010-06-03 | 2011-12-08 | Bayer Cropscience Ag | N-[(het)arylethyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues |
WO2011151368A2 (en) | 2010-06-03 | 2011-12-08 | Bayer Cropscience Ag | Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives |
WO2011154159A1 (en) | 2010-06-09 | 2011-12-15 | Bayer Bioscience N.V. | Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering |
WO2011154158A1 (en) | 2010-06-09 | 2011-12-15 | Bayer Bioscience N.V. | Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering |
US9574201B2 (en) | 2010-06-09 | 2017-02-21 | Bayer Cropscience Nv | Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering |
US9593317B2 (en) | 2010-06-09 | 2017-03-14 | Bayer Cropscience Nv | Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering |
WO2012010579A2 (en) | 2010-07-20 | 2012-01-26 | Bayer Cropscience Ag | Benzocycloalkenes as antifungal agents |
WO2012028578A1 (en) | 2010-09-03 | 2012-03-08 | Bayer Cropscience Ag | Substituted fused pyrimidinones and dihydropyrimidinones |
WO2012038480A2 (en) | 2010-09-22 | 2012-03-29 | Bayer Cropscience Ag | Use of biological or chemical control agents for controlling insects and nematodes in resistant crops |
WO2012038476A1 (en) | 2010-09-22 | 2012-03-29 | Bayer Cropscience Ag | Use of active ingredients for controlling nematodes in nematode-resistant crops |
WO2012045798A1 (en) | 2010-10-07 | 2012-04-12 | Bayer Cropscience Ag | Fungicide composition comprising a tetrazolyloxime derivative and a thiazolylpiperidine derivative |
WO2012052490A1 (en) | 2010-10-21 | 2012-04-26 | Bayer Cropscience Ag | N-benzyl heterocyclic carboxamides |
WO2012052489A1 (en) | 2010-10-21 | 2012-04-26 | Bayer Cropscience Ag | 1-(heterocyclic carbonyl) piperidines |
WO2012059497A1 (en) | 2010-11-02 | 2012-05-10 | Bayer Cropscience Ag | N-hetarylmethyl pyrazolylcarboxamides |
WO2012065944A1 (en) | 2010-11-15 | 2012-05-24 | Bayer Cropscience Ag | N-aryl pyrazole(thio)carboxamides |
WO2012065947A1 (en) | 2010-11-15 | 2012-05-24 | Bayer Cropscience Ag | 5-halogenopyrazolecarboxamides |
WO2012065945A1 (en) | 2010-11-15 | 2012-05-24 | Bayer Cropscience Ag | 5-halogenopyrazole(thio)carboxamides |
US9206137B2 (en) | 2010-11-15 | 2015-12-08 | Bayer Intellectual Property Gmbh | N-Aryl pyrazole(thio)carboxamides |
EP2460406A1 (en) | 2010-12-01 | 2012-06-06 | Bayer CropScience AG | Use of fluopyram for controlling nematodes in nematode resistant crops |
EP3092900A1 (en) | 2010-12-01 | 2016-11-16 | Bayer Intellectual Property GmbH | Active ingredient combinations comprising pyridylethylbenzamides and other active ingredients |
EP2460407A1 (en) | 2010-12-01 | 2012-06-06 | Bayer CropScience AG | Agent combinations comprising pyridylethyl benzamides and other agents |
WO2012072696A1 (en) | 2010-12-01 | 2012-06-07 | Bayer Cropscience Ag | Active ingredient combinations comprising pyridylethylbenzamides and other active ingredients |
WO2012072660A1 (en) | 2010-12-01 | 2012-06-07 | Bayer Cropscience Ag | Use of fluopyram for controlling nematodes in crops and for increasing yield |
EP3103338A1 (en) | 2010-12-01 | 2016-12-14 | Bayer Intellectual Property GmbH | Agent combinations comprising pyridylethyl benzamides and other agents |
EP3103340A1 (en) | 2010-12-01 | 2016-12-14 | Bayer Intellectual Property GmbH | Agent combinations comprising pyridylethyl benzamides and other agents |
EP3103334A1 (en) | 2010-12-01 | 2016-12-14 | Bayer Intellectual Property GmbH | Agent combinations comprising pyridylethyl benzamides and other agents |
EP3103339A1 (en) | 2010-12-01 | 2016-12-14 | Bayer Intellectual Property GmbH | Agent combinations comprising pyridylethyl benzamides and other agents |
WO2012089757A1 (en) | 2010-12-29 | 2012-07-05 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
EP2474542A1 (en) | 2010-12-29 | 2012-07-11 | Bayer CropScience AG | Fungicide hydroximoyl-tetrazole derivatives |
WO2012089721A1 (en) | 2010-12-30 | 2012-07-05 | Bayer Cropscience Ag | Use of substituted spirocyclic sulfonamidocarboxylic acids, carboxylic esters thereof, carboxamides thereof and carbonitriles thereof or salts thereof for enhancement of stress tolerance in plants |
WO2012089722A2 (en) | 2010-12-30 | 2012-07-05 | Bayer Cropscience Ag | Use of open-chain carboxylic acids, carbonic esters, carboxamides and carbonitriles of aryl, heteroaryl and benzylsulfonamide or the salts thereof for improving the stress tolerance in plants |
EP2494867A1 (en) | 2011-03-01 | 2012-09-05 | Bayer CropScience AG | Halogen-substituted compounds in combination with fungicides |
WO2012120105A1 (en) | 2011-03-10 | 2012-09-13 | Bayer Cropscience Ag | Use of lipochito-oligosaccharide compounds for safeguarding seed safety of treated seeds |
WO2012123434A1 (en) | 2011-03-14 | 2012-09-20 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
WO2012136581A1 (en) | 2011-04-08 | 2012-10-11 | Bayer Cropscience Ag | Fungicide hydroximoyl-tetrazole derivatives |
WO2012139892A1 (en) | 2011-04-15 | 2012-10-18 | Bayer Cropscience Ag | Substituted 5-(bicyclo[4.1.0]hept-3-en-2-yl)-penta-2,4-dienes and 5-(bicyclo[4.1.0]hept-3-en-2-yl)-pent-2-ene-4-ines as active agents against abiotic stress in plants |
EP2511255A1 (en) | 2011-04-15 | 2012-10-17 | Bayer CropScience AG | Substituted prop-2-in-1-ol and prop-2-en-1-ol derivatives |
WO2012139891A1 (en) | 2011-04-15 | 2012-10-18 | Bayer Cropscience Ag | Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants |
WO2012139890A1 (en) | 2011-04-15 | 2012-10-18 | Bayer Cropscience Ag | Substituted 5-(cyclohex-2-en-1-yl)-penta-2,4-dienes and 5-(cyclohex-2-en-1-yl)-pent-2-en-4-ines as active agents against abiotic stress in plants |
EP2997825A1 (en) | 2011-04-22 | 2016-03-23 | Bayer Intellectual Property GmbH | Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound |
WO2012168124A1 (en) | 2011-06-06 | 2012-12-13 | Bayer Cropscience Nv | Methods and means to modify a plant genome at a preselected site |
WO2013004652A1 (en) | 2011-07-04 | 2013-01-10 | Bayer Intellectual Property Gmbh | Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants |
WO2013020985A1 (en) | 2011-08-10 | 2013-02-14 | Bayer Intellectual Property Gmbh | Active compound combinations comprising specific tetramic acid derivatives |
US9265252B2 (en) | 2011-08-10 | 2016-02-23 | Bayer Intellectual Property Gmbh | Active compound combinations comprising specific tetramic acid derivatives |
WO2013026740A2 (en) | 2011-08-22 | 2013-02-28 | Bayer Cropscience Nv | Methods and means to modify a plant genome |
US10538774B2 (en) | 2011-08-22 | 2020-01-21 | Basf Agricultural Solutions Seed, Us Llc | Methods and means to modify a plant genome |
WO2013026836A1 (en) | 2011-08-22 | 2013-02-28 | Bayer Intellectual Property Gmbh | Fungicide hydroximoyl-tetrazole derivatives |
US9670496B2 (en) | 2011-08-22 | 2017-06-06 | Bayer Cropscience N.V. | Methods and means to modify a plant genome |
EP2561759A1 (en) | 2011-08-26 | 2013-02-27 | Bayer Cropscience AG | Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth |
WO2013034621A1 (en) | 2011-09-09 | 2013-03-14 | Bayer Intellectual Property Gmbh | Acyl-homoserine lactone derivatives for improving plant yield |
WO2013037717A1 (en) | 2011-09-12 | 2013-03-21 | Bayer Intellectual Property Gmbh | Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadizol-5(4h)-one derivatives |
WO2013037956A1 (en) | 2011-09-16 | 2013-03-21 | Bayer Intellectual Property Gmbh | Use of 5-phenyl- or 5-benzyl-2 isoxazoline-3 carboxylates for improving plant yield |
WO2013037958A1 (en) | 2011-09-16 | 2013-03-21 | Bayer Intellectual Property Gmbh | Use of phenylpyrazolin-3-carboxylates for improving plant yield |
WO2013037955A1 (en) | 2011-09-16 | 2013-03-21 | Bayer Intellectual Property Gmbh | Use of acylsulfonamides for improving plant yield |
WO2013041602A1 (en) | 2011-09-23 | 2013-03-28 | Bayer Intellectual Property Gmbh | Use of 4-substituted 1-phenyl-pyrazole-3-carboxylic-acid derivatives as agents against abiotic plant stress |
WO2013050410A1 (en) | 2011-10-04 | 2013-04-11 | Bayer Intellectual Property Gmbh | RNAi FOR THE CONTROL OF FUNGI AND OOMYCETES BY INHIBITING SACCHAROPINE DEHYDROGENASE GENE |
WO2013050324A1 (en) | 2011-10-06 | 2013-04-11 | Bayer Intellectual Property Gmbh | Combination, containing 4-phenylbutyric acid (4-pba) or a salt thereof (component (a)) and one or more selected additional agronomically active compounds (component(s) (b)), that reduces abiotic plant stress |
WO2013075817A1 (en) | 2011-11-21 | 2013-05-30 | Bayer Intellectual Property Gmbh | Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives |
WO2013079566A2 (en) | 2011-11-30 | 2013-06-06 | Bayer Intellectual Property Gmbh | Fungicidal n-bicycloalkyl and n-tricycloalkyl (thio)carboxamide derivatives |
WO2013092519A1 (en) | 2011-12-19 | 2013-06-27 | Bayer Cropscience Ag | Use of anthranilic acid diamide derivatives for pest control in transgenic crops |
WO2013098147A1 (en) | 2011-12-29 | 2013-07-04 | Bayer Intellectual Property Gmbh | Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives |
WO2013098146A1 (en) | 2011-12-29 | 2013-07-04 | Bayer Intellectual Property Gmbh | Fungicidal 3-[(1,3-thiazol-4-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives |
WO2013124275A1 (en) | 2012-02-22 | 2013-08-29 | Bayer Cropscience Ag | Use of succinate dehydrogenase inhibitors (sdhis) for controlling wood diseases in grape. |
WO2013127704A1 (en) | 2012-02-27 | 2013-09-06 | Bayer Intellectual Property Gmbh | Active compound combinations containing a thiazoylisoxazoline and a fungicide |
WO2013139949A1 (en) | 2012-03-23 | 2013-09-26 | Bayer Intellectual Property Gmbh | Compositions comprising a strigolactame compound for enhanced plant growth and yield |
WO2013153143A1 (en) | 2012-04-12 | 2013-10-17 | Bayer Cropscience Ag | N-acyl- 2 - (cyclo) alkylpyrrolidines and piperidines useful as fungicides |
WO2013156559A1 (en) | 2012-04-20 | 2013-10-24 | Bayer Cropscience Ag | N-cycloalkyl-n-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives |
WO2013156560A1 (en) | 2012-04-20 | 2013-10-24 | Bayer Cropscience Ag | N-cycloalkyl-n-[(trisubstitutedsilylphenyl)methylene]-(thio)carboxamide derivatives |
WO2013160230A1 (en) | 2012-04-23 | 2013-10-31 | Bayer Cropscience Nv | Targeted genome engineering in plants |
US11518997B2 (en) | 2012-04-23 | 2022-12-06 | BASF Agricultural Solutions Seed US LLC | Targeted genome engineering in plants |
EP2662363A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | 5-Halogenopyrazole biphenylcarboxamides |
EP2662370A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | 5-Halogenopyrazole benzofuranyl carboxamides |
EP2662361A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | Pyrazol indanyl carboxamides |
WO2013167545A1 (en) | 2012-05-09 | 2013-11-14 | Bayer Cropscience Ag | Pyrazole indanyl carboxamides |
WO2013167544A1 (en) | 2012-05-09 | 2013-11-14 | Bayer Cropscience Ag | 5-halogenopyrazole indanyl carboxamides |
EP2662360A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | 5-Halogenopyrazole indanyl carboxamides |
EP2662362A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | Pyrazole indanyl carboxamides |
EP2662364A1 (en) | 2012-05-09 | 2013-11-13 | Bayer CropScience AG | Pyrazole tetrahydronaphthyl carboxamides |
WO2013174836A1 (en) | 2012-05-22 | 2013-11-28 | Bayer Cropscience Ag | Active compounds combinations comprising a lipo-chitooligosaccharide derivative and a nematicide, insecticidal or fungicidal compound |
WO2014009322A1 (en) | 2012-07-11 | 2014-01-16 | Bayer Cropscience Ag | Use of fungicidal combinations for increasing the tolerance of a plant towards abiotic stress |
WO2014037340A1 (en) | 2012-09-05 | 2014-03-13 | Bayer Cropscience Ag | Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or salts thereof as active substances against abiotic plant stress |
WO2014060520A1 (en) | 2012-10-19 | 2014-04-24 | Bayer Cropscience Ag | Method for treating plants against fungi resistant to fungicides using carboxamide or thiocarboxamide derivatives |
WO2014060518A1 (en) | 2012-10-19 | 2014-04-24 | Bayer Cropscience Ag | Method of plant growth promotion using carboxamide derivatives |
WO2014060519A1 (en) | 2012-10-19 | 2014-04-24 | Bayer Cropscience Ag | Method for enhancing tolerance to abiotic stress in plants using carboxamide or thiocarboxamide derivatives |
WO2014060502A1 (en) | 2012-10-19 | 2014-04-24 | Bayer Cropscience Ag | Active compound combinations comprising carboxamide derivatives |
WO2014079957A1 (en) | 2012-11-23 | 2014-05-30 | Bayer Cropscience Ag | Selective inhibition of ethylene signal transduction |
EP2735231A1 (en) | 2012-11-23 | 2014-05-28 | Bayer CropScience AG | Active compound combinations |
WO2014079789A1 (en) | 2012-11-23 | 2014-05-30 | Bayer Cropscience Ag | Active compound combinations |
WO2014083089A1 (en) | 2012-11-30 | 2014-06-05 | Bayer Cropscience Ag | Ternary fungicidal and pesticidal mixtures |
WO2014082950A1 (en) | 2012-11-30 | 2014-06-05 | Bayer Cropscience Ag | Ternary fungicidal mixtures |
WO2014083033A1 (en) | 2012-11-30 | 2014-06-05 | Bayer Cropsience Ag | Binary fungicidal or pesticidal mixture |
WO2014083088A2 (en) | 2012-11-30 | 2014-06-05 | Bayer Cropscience Ag | Binary fungicidal mixtures |
WO2014083031A2 (en) | 2012-11-30 | 2014-06-05 | Bayer Cropscience Ag | Binary pesticidal and fungicidal mixtures |
WO2014086751A1 (en) | 2012-12-05 | 2014-06-12 | Bayer Cropscience Ag | Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cyloalkenyl ethynyl)-cyclohexanols as active agents against abiotic plant stress |
EP2740356A1 (en) | 2012-12-05 | 2014-06-11 | Bayer CropScience AG | Substituted (2Z)-5(1-Hydroxycyclohexyl)pent-2-en-4-inic acid derivatives |
EP2740720A1 (en) | 2012-12-05 | 2014-06-11 | Bayer CropScience AG | Substituted bicyclic and tricyclic pent-2-en-4-inic acid derivatives and their use for enhancing the stress tolerance in plants |
WO2014090765A1 (en) | 2012-12-12 | 2014-06-19 | Bayer Cropscience Ag | Use of 1-[2-fluoro-4-methyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl]-5-amino-3-trifluoromethyl)-1 h-1,2,4 tfia zole for controlling nematodes in nematode-resistant crops |
WO2014095826A1 (en) | 2012-12-18 | 2014-06-26 | Bayer Cropscience Ag | Binary fungicidal and bactericidal combinations |
WO2014095677A1 (en) | 2012-12-19 | 2014-06-26 | Bayer Cropscience Ag | Difluoromethyl-nicotinic- tetrahydronaphtyl carboxamides |
WO2014135608A1 (en) | 2013-03-07 | 2014-09-12 | Bayer Cropscience Ag | Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-heterocycle derivatives |
WO2014161821A1 (en) | 2013-04-02 | 2014-10-09 | Bayer Cropscience Nv | Targeted genome engineering in eukaryotes |
WO2014167009A1 (en) | 2013-04-12 | 2014-10-16 | Bayer Cropscience Ag | Novel triazole derivatives |
WO2014167008A1 (en) | 2013-04-12 | 2014-10-16 | Bayer Cropscience Ag | Novel triazolinthione derivatives |
WO2014170364A1 (en) | 2013-04-19 | 2014-10-23 | Bayer Cropscience Ag | Binary insecticidal or pesticidal mixture |
WO2014170345A2 (en) | 2013-04-19 | 2014-10-23 | Bayer Cropscience Ag | Method for improved utilization of the production potential of transgenic plants |
WO2014177514A1 (en) | 2013-04-30 | 2014-11-06 | Bayer Cropscience Ag | Nematicidal n-substituted phenethylcarboxamides |
WO2014177582A1 (en) | 2013-04-30 | 2014-11-06 | Bayer Cropscience Ag | N-(2-fluoro-2-phenethyl)carboxamides as nematicides and endoparasiticides |
WO2014206953A1 (en) | 2013-06-26 | 2014-12-31 | Bayer Cropscience Ag | N-cycloalkyl-n-[(bicyclylphenyl)methylene]-(thio)carboxamide derivatives |
WO2015004040A1 (en) | 2013-07-09 | 2015-01-15 | Bayer Cropscience Ag | Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress |
WO2015082586A1 (en) | 2013-12-05 | 2015-06-11 | Bayer Cropscience Ag | N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives |
WO2015082587A1 (en) | 2013-12-05 | 2015-06-11 | Bayer Cropscience Ag | N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives |
WO2016012362A1 (en) | 2014-07-22 | 2016-01-28 | Bayer Cropscience Aktiengesellschaft | Substituted cyano cycloalkyl penta-2,4-dienes, cyano cycloalkyl pent-2-en-4-ynes, cyano heterocyclyl penta-2,4-dienes and cyano heterocyclyl pent-2-en-4-ynes as active substances against abiotic plant stress |
WO2016096942A1 (en) | 2014-12-18 | 2016-06-23 | Bayer Cropscience Aktiengesellschaft | Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress |
WO2016166077A1 (en) | 2015-04-13 | 2016-10-20 | Bayer Cropscience Aktiengesellschaft | N-cycloalkyl-n-(biheterocyclyethylene)-(thio)carboxamide derivatives |
US11180751B2 (en) | 2015-06-18 | 2021-11-23 | The Broad Institute, Inc. | CRISPR enzymes and systems |
WO2018019676A1 (en) | 2016-07-29 | 2018-02-01 | Bayer Cropscience Aktiengesellschaft | Active compound combinations and methods to protect the propagation material of plants |
WO2018054829A1 (en) | 2016-09-22 | 2018-03-29 | Bayer Cropscience Aktiengesellschaft | Novel triazole derivatives and their use as fungicides |
WO2018054832A1 (en) | 2016-09-22 | 2018-03-29 | Bayer Cropscience Aktiengesellschaft | Novel triazole derivatives |
WO2018054911A1 (en) | 2016-09-23 | 2018-03-29 | Bayer Cropscience Nv | Targeted genome optimization in plants |
WO2018077711A2 (en) | 2016-10-26 | 2018-05-03 | Bayer Cropscience Aktiengesellschaft | Use of pyraziflumid for controlling sclerotinia spp in seed treatment applications |
WO2018104392A1 (en) | 2016-12-08 | 2018-06-14 | Bayer Cropscience Aktiengesellschaft | Use of insecticides for controlling wireworms |
WO2018108627A1 (en) | 2016-12-12 | 2018-06-21 | Bayer Cropscience Aktiengesellschaft | Use of substituted indolinylmethyl sulfonamides, or the salts thereof for increasing the stress tolerance of plants |
EP3332645A1 (en) | 2016-12-12 | 2018-06-13 | Bayer Cropscience AG | Use of substituted pyrimidine diones or their salts as agents to combat abiotic plant stress |
US11591601B2 (en) | 2017-05-05 | 2023-02-28 | The Broad Institute, Inc. | Methods for identification and modification of lncRNA associated with target genotypes and phenotypes |
US12297436B2 (en) | 2017-05-18 | 2025-05-13 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
WO2019025153A1 (en) | 2017-07-31 | 2019-02-07 | Bayer Cropscience Aktiengesellschaft | Use of substituted n-sulfonyl-n'-aryl diaminoalkanes and n-sulfonyl-n'-heteroaryl diaminoalkanes or salts thereof for increasing the stress tolerance in plants |
WO2019060746A1 (en) | 2017-09-21 | 2019-03-28 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
WO2019126709A1 (en) | 2017-12-22 | 2019-06-27 | The Broad Institute, Inc. | Cas12b systems, methods, and compositions for targeted dna base editing |
US10968257B2 (en) | 2018-04-03 | 2021-04-06 | The Broad Institute, Inc. | Target recognition motifs and uses thereof |
US11999767B2 (en) | 2018-04-03 | 2024-06-04 | The Broad Institute, Inc. | Target recognition motifs and uses thereof |
WO2019233863A1 (en) | 2018-06-04 | 2019-12-12 | Bayer Aktiengesellschaft | Herbicidally active bicyclic benzoylpyrazoles |
WO2020131862A1 (en) | 2018-12-17 | 2020-06-25 | The Broad Institute, Inc. | Crispr-associated transposase systems and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
AU4970793A (en) | 1994-03-15 |
WO1994004693A3 (en) | 1994-03-31 |
CA2143316A1 (en) | 1994-03-03 |
AU685065B2 (en) | 1998-01-15 |
EP0658208A1 (en) | 1995-06-21 |
US5859333A (en) | 1999-01-12 |
GB9218185D0 (en) | 1992-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1994004693A2 (en) | Novel plants and processes for obtaining them | |
US6194638B1 (en) | Alteration of hemicellulose concentration in plants | |
Prioul et al. | Expression of ADP-glucose pyrophosphorylase in maize (Zea mays L.) grain and source leaf during grain filling | |
DE69937352T2 (en) | CELLULOSE SYNTHESES AND THEIR USES | |
Chourey et al. | Tissue-specific expression and anaerobically induced posttranscriptional modulation of sucrose synthase genes in Sorghum bicolor M. | |
AU2696492A (en) | Novel plants and processes for obtaining them | |
EP0611395A1 (en) | Improved supersweet corn | |
DE69132758T2 (en) | Plasmids for the production of transgenic plants which have changed their habit and yield | |
Kueh et al. | Proline accumulation in a barley mutant resistant to trans-4-hydroxy-L-proline | |
US6680429B1 (en) | Starchless variety of pisum sativum having elevated levels of sucrose | |
AU8262398A (en) | Receptor kinase, bin1 | |
EA008669B1 (en) | A method of increasing the total or soluble carbohydrate content or sweetness of an endogenous carbohydrate by catalysing the conversion of an endogenous sugar to an alien sugar | |
US20030051271A1 (en) | DNA sequences for an amino acid transporter plasmids, bacteria, yeasts and plants containing a transporter and their use | |
JPH0279979A (en) | Self-incompatible gene | |
WO2024125590A1 (en) | Polynucleotide, protein, biological material, and use thereof in improving quality of plant fruit | |
US6177614B1 (en) | Control of floral induction in plants and uses therefor | |
US6518486B1 (en) | Enhanced storage organ production in plants | |
CN112708603B (en) | Application of rice ARE2 gene in regulation of nitrogen metabolism in plants | |
US7495152B2 (en) | Identification and characterization of a novel alpha-amylase from maize endosperm | |
US6831168B1 (en) | Aldehyde oxidase gene derived from plant and utilization thereof | |
AU741854B2 (en) | Control of floral induction in plants and uses therefor | |
EA018689B1 (en) | Boron transporter polypeptide, encoding nucleic acid thereof and use thereof | |
Gengenbach et al. | Alterations in the Biosynthesis of Lysine, Threonine, and Methionine by Tissue Culture Approaches in Maize | |
Beecher | Mini-Symposium: Gametophytic Self-incompatibility | |
WO1999023200A2 (en) | The uridine diphosphate glucose dehydrogenase gene and its role in altering plant growth and plant characteristics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BB BG BR BY CA CZ FI HU JP KP KR KZ LK MG MN MW NO NZ PL RO RU SD SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BB BG BR BY CA CZ FI HU JP KP KR KZ LK MG MN MW NO NZ PL RO RU SD SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2143316 Country of ref document: CA Ref document number: 1994908157 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1994908157 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08392816 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1994908157 Country of ref document: EP |